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ABSTRACT 
 
 
Depression is a mood disorder, which represents one of the major causes of 
disability of people worldwide.  The major features of this disorder are the neuronal 
plasticity impairment, abnormal neuronal network and in some case a cell loss but the 
mechanism whereby they occur is still not fully understood. Antidepressant drugs, a 
common choice for depression treatment, target monoamine neurotransmitters systems 
decreasing serotonin and norepinephrine reuptake and consequently, promoting the 
restoring of the monoamine neurotransmission. Although a fast increase in monoamine 
levels with antidepressant administration, the therapeutic effects takes longer to be 
visible. Recent studies found that antidepressant drugs can increase the neurotrophin 
BDNF expression even before the rise of BDNF mRNA transcription, suggesting that 
they can potentiate postregulation of BDNF. These results have raised the working 
hypothesis of a role of miRNAs modulated by antidepressants in the BDNF gene 
regulation. With this purpose, we have evaluated the effect of miRNAs modulated by 
antidepressant treatment in the neuronal morphology and survival as well as their effect 
on BDNF expression.  
Our results suggest that mir-302b, mir-214 and mir-136 do not cause 
morphological changes in neuronal morphology and survival since the up- or 
downregulation do not represented a differential morphological behavior. 
Measurements of BDNF expression levels modulating miRNAs were challenging; 
however, as many miRNAs are putative or validated targets for BDNF gene, mostly in 
the 3’UTR, it was evaluated the meaning of the 3’ UTR long for neuronal cells. 
Truncation of the long 3’ UTR BDNF led to a decrease of the total dendritic length at 6 
and 12 DIV although the number of primary and dendrites remained unaltered. 
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Moreover, it was visible a lower number of mushroom spines at distal fields of matured 
neurons and a lower percentage of colocalization with PDS-95 and Syn I at 6, 9 and 12 
DIV. 
Taken together, the results shows that the absence of BDNF transcripts with the 
long 3’UTR (BDNFlox mice) do not have major impact on neuronal shape but rather a 
deficit in the total dendritic length and impairment of the synaptic maturation and 
connectivity. These evidences may be important to understand the role of the miRNAs 
on depression´s recovery. Since was not observed a neuronal morphological change 
acting on single miRNAs it may be possible that the BDNF translational regulation 
requires multiple miRNAs and translation factors acting in a cooperative but specific 
manner on the two populations of BDNF (BDNF 3’UTR short, BDNF 3’UTR long). 
This differential regulation can be underlined by detailed control of the synaptic 
maturation and activity in physiological and pathological conditions. 
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RESUMO 
 
 
A depressão é uma desordem psiquiátrica que representa uma das maiores causas 
de incapacidade em todo o Mundo, sendo que é caracterizada pelo enfraquecimento da 
plasticidade neuronal, anormal rede neuronal e, somente em alguns casos, perda celular. 
No entanto, o mecanismo pelo qual surgem estas alterações neuronais é ainda 
desconhecido. Os antidepressivos, largamente usados no tratamento de depressão têm 
como alvo os sistemas de transmissão de monoaminas, inibindo o reuptake destes 
neurotransmissores restabelecendo a transmissão monoamínica. Apesar de ser 
verificado um rápido aumento dos níveis de monoaminas com a administração de 
antidepressivos, o seu efeito terapêutico apenas se torna visível após um longo período. 
Estudos recentes demonstraram que os antidepressivos podem aumentar os níveis da 
neurotrofina BDNF antes de ser verificado um aumento do BDNF mRNA, o que sugere 
um efeito modulador mediado pelos antideprressivos na tradução de BDNF. Tais 
resultados originaram a hipótese de trabalho que se assenta na possibilidade de uma 
acção reguladora dos miRNAs na tradução do BDNF. Posto isto, teve-se como 
objectivo a avaliação do efeito de miRNAs modulados previamente por medicamentos 
antidepressivos na morfologia e sobrevivência neuronal, e igualmente na tradução de 
BDNF. 
Os nossos resultados sugerem que os mir-302b, mir-214 e mir-136 não levam a 
alterações da morfologia e sobrevivência de neurónios do hipocampo com a sobre- ou 
subregulação destes miRNAs. A quantificação dos níveis de expressão de BDNF após 
modulação com os miRNAs mostrou-se de difícil execução; porém, tendo em conta que 
um número significativo de miRNAs é validado ou previsto para interagir com o gene 
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de BDNF, principalmente na 3’ UTR, foi avaliado o significado funcional do 3’ UTR 
nas células neuronais. 
O truncamento da porção longa da 3’ UTR (long 3’ UTR) resultou numa 
diminuição do comprimento dendrítico total a 6 e 12 DIV embora nenhuma alteração 
tenha sido verificada no número de dendrites primárias e secundárias. Para além disso, 
foi visível uma diminuição do número de espículas “mushroom” em regiões distais de 
neurónios maduros e uma menor percentagem de colocalização entre PSD-95 e SynI a 
6, 9 e 12 DIV.  
Finalmente, os resultados obtidos mostram que a ausência de transcriptos BDNF 
com o  “long 3’UTR” não têm um pronunciado efeito na forma dos neurónios mas são 
sim os responsáveis por um défice no comprimento dendrítico total, assim como na 
maturação sináptica e conectividade. Estas evidências podem ser importantes para 
entender o papel dos miRNAs na recuperação da depressão. Tendo em conta que não 
foram observadas alterações morfológicas com um único miRNA pode ser possível que 
a regulação da tradução de BDNF requira a acção de múltiplos miRNAs na regulação 
dos dois tipos de transcriptos de BDNF (short 3’ UTR e long 3’ UTR). Esta regulação 
diferencial pode ser analisada por um controlo detalhado da maturação sináptica e sua 
actividade em condições fisiológicas e patológicas. 
 
 
 
Palavras-chave: Depressão, Antidepressivos, miRNAs, BDNF 
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1. INTRODUTION 
  
 
Principles of neuronal plasticity  
 
Neuronal plasticity consists in the capacity of the Central Nervous System (CNS) 
to adapt to a changing environment through structural and functional rearrangement of 
neuronal connectivity. Neuronal plasticity is also a crucial element in injury recovery 
and in learning and memory (Pearson-Fuhrhop et al., 2009). This mechanism undergoes 
through generation of newborn neurons, degeneration of dispensable neurons and 
reorganization of synaptic connections. At cellular level, plasticity is determined by 
dendritic spines formation and their pruning and remodeling (Ethell et al., 2005), 
calcium channel regulation, alterations in NMDA receptors or in AMPA trafficking 
(Cull-Candy et al., 2004). Functionally, two well-known forms of plasticity are long-
term potentiation (LTP) and long-term depression (LTD), the long lasting strengthening 
and weakening of synaptic connections between neurons. 
Neuronal plasticity is initiated and maintained by synaptic activity, which in turn 
is stimulated by excitatory neurotransmitters, which cause an action potential on 
postsynaptic neurons and trigger transcription of genes involved in restructuring of 
CNS. Defects in this process will impair adaptation of the CNS to new challenges 
causing not only the disruption of homeostasis but increasing also the susceptibility of 
neuronal circuits to environmental variations. In this way, a failure to adapt may lead to 
structural and functional damages of specific brain regions, which in turn can cause 
progressive neurodegeneration triggering diverse pathologies. 
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Neurotrophic factors as marker of plasticity 
 
Neurotrophic factors are growth factors that participate in the processes that 
guarantee neuronal survival. Neurons are dependent of these molecules for their 
survival and to the establishment of neuronal network and neuronal plasticity, including 
the modulation and remodeling of axonal and dendritic growth, membrane receptor 
trafficking, neurotransmitter release and formation of synapses. The neurotrophin 
family are constituted by four different proteins structurally related: nerve growth factor 
(NGF) (Levi-Montalcini et al., 1966), brain-derived neurotrophic factor (BDNF) (Barde 
et al., 1982), neurotrophin 3 (NT-3) and neurotrophin 4 (NT-4) (Hohn et al., 1990). 
According to their affinity they can bind to two classes of membrane receptors: the 
tropomyosin receptor kinase (trk) family (Barbacid et al., 1994) and the p75 
neurotrophin receptor (p75NTR), a member of tumour necrosis factor (TNF) receptor 
superfamily (Rodriguez-Tébar et al., 1990). 
Neurotrophins are synthesized as precursor protein (pro-neurotrophins) that can 
be processed intracellularly, originating the mature and biologically active form of this 
protein, or instead be released as a pro-neurotrophin through regulated pattern (Mowla 
et al., 1999), modulating the development and maturation of neuronal circuits. 
Neurotrophins bind to trk receptors leading to their dimerization and 
autophosphorylation, allowing the alteration of their conformation to an activated state 
(Ullrich et al., 1990). Subsequently, trk receptors phosphorylate intracellular molecules 
activating signaling cascades. The effects mediated by mature neurotrophins are due to 
activation of high affinity full-length trk receptor, which activates pathways specifically 
involved in neuronal survival and growth. The four neurotrophins have diverse affinity 
to these receptors: NGF binds to trkA receptor, BDNF and NT-4 to trkB and NT-3 
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binds mostly to trkC but under some circumstances it may also bind to trkA or trkB 
(Barbacid et al., 1994; Cohen-Cory et al., 2010). In the other hand, pro-neurotrophins 
have high affinity to another type of receptors, the p75NTR receptor, which has low 
affinity to mature form of neurotrophin but high affinity for pro-neurotrophin, activating 
intracellular signaling pathways involved in cellular death (Lee et al., 2001; Dechant et 
al., 2002). Thus, mature and precursor form of neurotrophins and their binding to 
different receptors leads to divergent effects.  
 
Brain-derived Neurotrophic Factor 
 
BDNF is the best well characterized neurotrophin and is currently seen as a factor 
with multiple and crucial functions. This neurotrophin was initially discovered through 
its ability to promote and support the survival of chick sensory neurons during 
development, being similar to fibroblast growth factor (FGF) (Barde et al., 1982). 
BDNF plays a key role in neuronal survival and maturation during development and 
neuronal plasticity in adulthood. 
BDNF has specific mechanisms of transcription, translation and posttranslational 
modifications. BDNF gene has a complex and a well-conserved organization among 
mammals (Maisonpierre et al., 1991; Tettamanti et a., 2010), suggesting that regulation 
of its expression has a strong functional significance. Like the other neurotrophins, 
BDNF is synthesized as propeptide that may follow two different secretory pathways to 
either the regulated (i.e. release in response to stimuli) or constitutive pathway (i.e. 
spontaneous release). BDNF shows in majority of neurons a distal dendritic targeting of 
secretory granules through regulated pathway whereas constitutive pathway occurs 
mainly in the soma (Brigadski et al., 2005). Pro-BDNF is formed in the soma and can 
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be cleaved in the endoplasmic reticulum (Mowla et al., 2001) giving rise the mature 
neurotrophin or remaine in the unprocessed form. Pro-BDNF can be processed 
intracellularly by furin and proconvertases generating mature BDNF; otherwise, it can 
be cleaved extracellularly by metalloproteases (MMPs) such as plasmin (Lee et al., 
2001; Teng et al., 2005). The targeting of BDNF for regulated or constitutive pathways 
is determined in Golgi complex through its binding to intracellular sortilin which 
promotes a correct folding of the mature domain (Teng et al., 2005; Lu et al., 2005). 
Subsequently, there is an interaction between sorting motif within mature domain and 
carboxypeptidase (CPE), which targets mature BDNF to regulated pathway (Lou et al., 
2005). Mature BDNF can be packaged into synaptic vesicles present both in axon 
terminals (presynaptic site) and dendrites (postsynaptic site) of glutamatergic neurons 
and be released in activity-dependent manner through an influx of calcium (Wu et al., 
2004; Matsuda et al., 2009). 
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Fig.1: Synthesis and sorting of BDNF to either constitutive or regulated secretory pathway. Pro-BDNF is 
synthesized in the endoplasmic reticulum (ER) and interacts with sortilin in the Golgi complex what 
promotes the folding of the mature domain. Subsequently, mature domain can bind to carboxypeptidase E 
(CPE) sorting mBDNF to secretory vesicles of the regulated pathway, which transport BDNF to 
dendrites, or axon to its release; if this interaction doesn´t happens BDNF is sorted to constitutive 
pathway. Instead of mature BDNF even proBDNF can be released by neurons if the proneurotrophin isn´t 
cleaved by furin or protein convertases (as protein convertase 1- PC1). In these cases, proBDNF can be 
cleaved extracellularly by metalloproteinases (MMP) and plasmin   (Bai Lu; 2005).  
 
 
As mature and precursor BDNF activate trkB receptor or p75NTR, respectively, 
different effects can be achieved. Stimulation of the trkB receptor stimulation activates 
patterns involved in cell survival (such as mitogen-activated protein kinase (MAPK), 
phosphatidylinositol 3-kinase (PI3K) and phospholipase C-ƴ (PLC- ƴ) pathways) while 
p75NTR stimulation leads to apoptosis (activating caspase cascades, jun kinase and also 
p53 pathways) (Fišar et al., 2010).  
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The BDNF gene consists in multiple alternative 5´untranslated exons in different 
number according to the species (ten in humans, eight in rodents and six or even less in 
other vertebrates) each of them under individual promoter regions, and a single exon 
coding for the entire BDNF pre-protein amino acid sequence. The transcription of 
BDNF exons are achieved by individual promoters differentially regulated taking into 
account the developmental stage, target tissue and neuronal activity (Aid et al., 2007). 
The regulation of promoters by a wide range of stimuli and their activation by neuronal 
activity and DNA methylation enables the expression and target of their transcripts to 
different brain regions, different cell types and even different regions at the same cell 
(soma vs. dendrites) ensuring the precise spatial and temporal BDNF expression 
(Timmusk et al., 1993; Tongiorgi et al., 2006). Besides transcriptional regulation also 
BDNF translation through regulatory elements serve as another control mechanism to 
avoid translation of BDNF when is not needed (Croll et al., 1999; Cunha et al., 2009). 
In addition to the possible BDNF isoforms obtained by transcription of different 
5’UTR exons through differential activity of promoters, additional complexity is 
provided due to the presence of alternative sites of polyadenilation in 3’UTR which give 
rise to two populations of BDNF transcripts: with a short 3´untranslated region (UTR) 
or with a long 3´untranslated region (Fig.2) (Timmusk et al., 1993).  
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Fig.2: Scheme of rat BDNF gene structure and its transcripts. The eight non-coding exons of rat are 
spliced with the 3’ exon-coding for BDNF protein (exon IX), originating different BDNF isoforms. 
Moreover, transcription can be initiated befor exon IX what leads to the IXA transcripts. In addition, 
transcripts can be polyadenilated at two polyadenilation sites (represented as arrows), what creates three 
transcripts variants for the exon II (IIA, IIB and IIC). Lines represent introns, boxes the exons and 
protein-coding exons are represented as solid boxes. (Aid et al., 2007).  
 
 
The existence of these two pools of transcripts gave rise to the debate of their 
functional meaning in neuronal population. To study the role of these two types of 
transcripts were generated a specific mice strain, truncated for long 3’UTR, namely 
BDNFlox mice (Gorski et al., 2003). This mouse is created using a cre-site-specific 
DNA recombinase system in which lox sites are inserted into exon 5 (the protein-coding 
exon) of BDNF, upstream of lox sites a trimerized polyadenilation signal (Simian Virus 
40 (SV40)) and downstream an Escherichia coli lac Z gene. Following the lac Z gene 
there is an Flp recombinase target (FRT)-flanked phosphoglycerate kinase (PGK) 
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neomycin cassette. The Cre-mediated recombinase deletes the polyadenilation signals 
abolishing the long portion of the 3’UTR of BDNF (Gorski et al, 2003). 
 
 
 
Fig.3: Cre-site-specific DNA recombinase system used to generate BDNFlox mice. Exon V, the BDNF 
coding exon, is shown schematically at the top of the figure in which the open bar identifies the 5’UTR; 
the shaded bar the pro domain of the BDNF; the filled bar the mature hormone region, flanked by lox 
sites (the filled triangles), and followed by lacZ, a SV40 intron-polyA (open bar) and a FRT-flanked PGK 
neomycin cassete. Location of the splice acceptor (SA) is denoted by an arrow. After Cre-mediated 
recombination BDNF-coding sequences in exon V are excised and lacZ is brought downstream of the 
splice acceptor site and under control of BDNF promoters (Gorski et al, 2003). 
 
 
So far, had been suggested that transcripts with short 3’UTR are restricted to the 
soma while transcripts with long 3’UTR can be present in the soma or targeted to 
dendrites (An et al., 2008). However, two another studies showed that the two 
populations of transcripts are capable of being targeted to dendrites but in a differents 
extent (Yoneda et al., 2010; Baj et al., 2011) since long 3’UTR BDNF transcripts can 
reach more distal dendritic fields in comparison with short 3’UTR BDNF transcripts. 
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The knowledge of subcellular localization is important to understand the contribution of 
each type of transcript to local changes in neuronal structure and function. 
 
BDNF implication in brain function 
 
BDNF is the most abundant growth factor in the brain and is essential for 
maintenance of neuronal function and neurogenesis.  In cases in which BDNF levels are 
low the brain shows structural abnormalities and reduced neuronal plasticity. The level 
of BDNF should be strictly regulated to permit a balance between the enhancing of 
axon arbor growth and its connectivity with its targets and the destabilization and 
pruning of axon terminals. A reduced BDNF level induces presynapric site 
destabilization and axon pruning (Hu et al., 2005) what results in a smaller number of 
presynaptic terminals and excitatory synapses (Luikart et al., 2005). Thus, BDNF is not 
only necessary to initiate axon branch but also to the stability of the axon arbor already 
formed as well as the synaptic connections. 
The development of growth axon cone is possible due to axon guidance molecules 
that activate intracellular signaling pathways responsible for the growth of filopodia and 
lamellipodia. However, BDNF in neuronal cultures also stimulates filopodia and 
lamellipodia dynamics along the axon by inducing localized changes in the actin 
cytoskeleton (Gibney et al., 2003; Yuan et al., 2003). Observations made in vivo had 
shown that axon guidance and pathfinding are independent of BDNF action as 
demonstrated by normal guidance of major afferent projections in trkB mutant mice. 
Nevertheless, events that follow successful axon pathfinding depend on BDNF 
otherwise synaptic connectivity of axon with targets is affected (Rico et al., 2002; 
Huang et al., 2007).  
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In addition, BDNF has a crucial role in the modulation of the number of synaptic 
vesicles docked in the active zone of presynaptic terminals, which is probably 
proportional to neurotransmitter release. The amount of docked vesicles can be altered 
upon disturbance of BDNF signaling (Shen et al., 2006). Indeed, deficits in trk signaling 
results in the decrease of the expression of synaptic proteins involved in synaptic vesicle 
docking and fusion, decreasing the number of docked vesicles at active zones and, 
consequently, downregulating neurotransmitter release (Lin et al., 2000). On the 
contrary, exposure to BDNF increases the number of synaptic vesicles docked at active 
zone in excitatory synapses in hippocampal neuronal cultures (Tyler et al., 2001). 
Nevertheless, BDNF also acts under inhibitory synapses inducing glutamic acid 
decarboxylase (GAD) expression, explaining the reason why alterations in trk signaling 
and reduced levels of BDNF leads to a decrease in the number of GABAergic boutons 
and synaptic specialization (Rico et al., 2002; Kohara et al., 2007). Thereby, BDNF has 
a crucial role in balancing the number of excitatory and inhibitory synapses in adult 
brain. 
 
Dendritic spines as vital component of synaptic activity 
 
Most of synaptic activity takes place in dendritic spines, a dendritic protusion that 
contains a scaffold rich in elements of the biochemical signaling machinery. These 
structures mediate the excitatory neurotransmission in the brain and are present as 
thousands on pyramidal cells.  
Spines are dynamic structures that can present a wide range of sizes and shapes 
during their lifetime. Generally, spines are morphological characterized as structures 
with a bulbous head connected to dendritic shaft by a narrow neck (Sorra and Harris, 
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2000). The spine head contains the postsynaptic density, constituted by ion channels 
and cell surface receptors in scaffold with cytoplasmic scaffolding and signaling 
proteins (Li and Sheng, 2003), which permit the link between the postsynaptic density 
to actin filaments, the main cytoskeleton component of dendritic spines (Dent et al., 
2011). Dendritic spines are mostly represented by three types of spines: “mushroom-
like” spines which have a big round head and a tiny spine neck that makes the 
connection between the spine and dendrite; “stubby” spines which are short and without 
a defined spine neck and “thin” spines which length is bigger than the neck which in 
turn is similar to spine head (Jen claude Béique 2012). The spine development and 
maturation is regulated in a synapse-specific manner (Jen claude Béique 2012). 
Development of dendritic spines will promote the morphological and biochemical 
changes in a manner that allows the passage from stubby to thin spines and finally 
mushroom spines, the most mature spine type (Grutzender et al., 2002). Spine formation 
is regulated by different components. One of them is BDNF which contributes to spine 
formation, promoting the reshuffle of early filopodia-mediated contacts (Matsutani et 
al., 2004). The promotion of spine maturation can be evaluated through the amount of 
postsynaptic specializations, which is higher or lower depending of the increase or 
decrease of BDNF levels (Sanchez et al., 2006). 
 
 
12 
 
Fig.4: Three-dimension illustration of different types of spines of a neuronal dendritic segment. 
Mushroom spines have a big spine head and a small neck; “stubby” spines are characterized by short and 
without a defined spine neck; “thin” spines are long spines with a small head and branched spines are like 
two thin spines (Harris et al., 2008). 
 
Depression: a worldwide disorder 
 
Depression is a common mood disorder affecting 121 million people worldwide 
(Mouillet-Richard et al., 2012) among children, adolescents, adults and elderly and 
according to World Health Organization it is predicted to be between of the top three of 
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causes of disability by 2030. The symptoms of this stress-related disorder manifest as 
changes in cognitive functions, learning, memory and emotions (Lipsky et al, 2002) 
which seem to be caused by neuronal plasticity impairment, abnormal neuronal network 
and in some cases atrophy or even cell loss produced by stress events, characteristics of 
low adaptation capacity of CNS to the environment (Fišar et al., 2009; Drzyzga et al., 
2009).  
An interesting point that drew attention of many researchers was the higher 
predisposition of certain individuals to develop depression which could indicate that, at 
least in part, depression is genetically-determined (Levinson 2005). Stressful events, 
defined as alterations of the homeostasis, are in fact a risk factor for depression. Despite 
genetically-determined susceptibility-threshold specific for each individual to variations 
in brain environment it is also accepted that stress events occurred in critical period of 
brain development can increase the vulnerability to stress and favour the onset of 
anxiety disorders (Muiños-Gimeno et al., 2011). However, it is important to notice that 
depending on the type of stress event and the affected brain regions the consequences in 
the brain function can be completely different. A soft stress in the hippocampus 
increases learning and memory processes (Luine et al., 1996) whereas severe stress has 
the opposite effects, impairing Long-Term Potentiation (LTP) (Kim and Diamond, 
2002). Moreover, different brain areas have diverse pathways to respond to stimuli 
explaining why continuous stress in the hippocampus and prefrontal cortex leads to 
neuronal atrophy while in amygdale it causes neuronal hypertrophy (Sapolsky, 2003). 
Nevertheless, independently of stress rate and its effect in neuronal network, seems to 
be a common characteristic the long lasting effects on vulnerable individuals (Roth et 
al., 2009).  
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Moreover, depressive patients present a reduction of the hippocampus volume in 
about 4-5% when compared with healthy individuals, which is correlated with disease 
duration and consequent dysfunction (Sheline et al., 2003). 
Activation of different patterns by stressors can explain the duration of the effects 
mentioned above. One of the possible mechanisms consists in the dysfunction of the 
hypothalamus-pituitary-adrenal (HPA) axis. Disturbance of this axis and alteration of 
glucocorticoids receptors expression and signaling leads to the lack on the recognition 
of glucocorticoids levels, which decrease the negative feedback and consequently 
increase the level of glucocorticoids in circulation and the response to stressors, 
explaining the long-lasting effects of stress events (Min et al., 2012). Other possible 
mechanism is related to the impairment of neuronal plasticity and lower monoamine 
neurotransmission (Massart et al., 2012). Different studies performed with depressed 
patients’ brains show brain structural alterations, decrease on the expression of neuronal 
markers as well as alterations in neurotrophins expression (Fišar et al., 2009). In this 
point, neurotrophic factors (NTFs) can play an important role and be a connection 
between stress and psychiatric disorders.  
The summary of results obtained until now allowed the stipulation of two 
different but potentially complementary hypotheses that can be implicated in the origin 
of this depression. The first one, the monoamine hypothesis, poses that depression is a 
result of the deficit in serotonin and noradrenaline neurotransmission while the 
neurotrophic hypothesis suggests that depression is caused by the diminished levels of 
neurotrophins, more specifically, BDNF. 
BDNF has been seen as a component that takes part in disease pathologies or 
treatment of many psychiatric diseases. The mechanism whereby psychiatric disorders 
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occur is not fully understood so far, however BDNF seems to be involved in the 
pathophysiology and therapeutic mechanisms of depression (Fuchikami et al 2010).  
 
Antidepressant drugs 
 
Antidepressant drugs have been used for the past 50 years but the exact 
mechanism of their action is not fully understood. These drugs include the selective 
serotonin reuptake inhibitors (SSRIs) (Cramer et al, 2009), norepinephrine reuptake 
inhibitors (NRIs) or inhibitors of both as serotonin norepinephrine reuptake inhibitors 
(SNRIs) (Kellermann et al., 2012) which target monoamine neurotransmitters systems 
in order to increase signaling at the synapses. Their therapeutic effect passes through the 
increase of monoamine neurotransmitter to restore the compromised neurotransmission 
in noradrenergic and serotorinergic system. However, their effects are only visible when 
administrated for long periods, taking about 6-8 weeks to produce therapeutic effects, 
despite of the increased synaptic monoamine level hours after antidepressant treatment, 
demonstrating that the recovery of this synaptic transmission cannot be the only 
outcome produced by antidepressants to explain the extent of their clinical effects (Yu 
et al., 2011). The delayed efficacy of antidepressants could be due to a requirement of 
neuroadaptative mechanisms that may increase neuronal plasticity.  Chronic 
antidepressant administration of both 5-HT and norepinephrine selective inhibitors 
increases cAMP-CREB signaling that will increase BDNF expression (Duman and 
Monteggia et al., 2006; Nibuya et al., 1996), restoring its normal level and neuronal 
plasticity. Furthermore, the stimulus caused by the antidepressants can also have an 
impact in dendritic growth and arbor complexity (Magill et al., 2010). 
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Thus, antidepressants can stimulate through the mosulation of neurotrophic 
factors the development of neuronal morphology and synaptic plasticity that is 
important for the behavioral effects of the treatment.  
 
Effects of antidepressant treatment on BDNF level 
 
Antidepressants are capable of modulate BDNF expression provoking its increase 
in situations in which its expression is abnormally low, restoring defective signaling 
systems, enhancing the neuronal plasticity, supporting synaptic connectivity and 
replacing neuronal cytoarchitecture (Calabrese et al., 2009, Castren et al., 2007, Russo-
Neudstadt and Chen, 2005). These drugs increase mature BDNF form level in synaptic 
compartments and restore trkB signaling (Calabrese et al., 2007), suggesting that BDNF 
can be a huge effector of their mechanism. This increase in mBDNF levels could be due 
to an increase of local translation of BDNF transcripts or to the trafficking of BDNF 
protein from other compartments (Molteni et al., 2009; Tongiorgi et al., 2008). 
The consequences on BDNF expression will depend on the time of exposure to 
antidepressant treatment. Chronic treatments increase BDNF expression (Xu et al., 
2004; Tsankova et al., 2006) while acute treatment have no effect or can even reduce 
total BDNF mRNA (Drzyzga et al., 2009).  Moreover, different classes of 
antidepressants act differentially on BDNF transcription recruiting different BDNF 
promoters and even reverting epigenetic modifications caused by stress events (Yu et 
al., 2011).  
For antidepressants-mediated behavioral effects TrkB signaling is essential 
(Saarelainen et al., 2003). Antidepressants can cause a higher phosphorylation of trkB 
receptor increasing its signaling and at the same time increasing the phosphorylation of 
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CREB (Castren et al., 2009), a mediator of BDNF gene transcription that will result in 
the increase of BDNF expression and trkB activation. Therefore, neuronal plasticity and 
cellular functions are restored. 
It is thought that one of the main mechanisms through which BDNF contributes to 
antidepressant effect is its ability to promote translation of BDNF. 
 
Dysregulation of microRNAs in depression 
 
The recent discovery that BDNF can exert its control on protein translation 
through regulation of miRNAs has opened completely new perspectives for the role of 
neurotrophic factors and miRNAs. 
Gene transcription and translation is highly regulated by different mechanisms 
being one of them the regulation mediated by miRNAs (miRs). MiRNAs are a class of 
small non-coding RNAs with a length of about 22 nucleotides that participate in 
fundamental intracellular mechanism involved in gene expression regulation (Yiing et 
al., 2006). More than 400 miRNAs have already been identified in human and 
chimpanzee brains (Bushati et al., 2008) but is estimated that more than 1000 miRNAs 
could be expressed in human brain. Despite of many miRNAs being conserved between 
species, some miRNAs seem to be specific to human, suggesting a recent origin 
(Bushati 2008). In the genome, miRs can be located in introns of protein-coding and 
non-coding genes, exons of non-coding genes or in intragenic regions (Kim et al., 
2005). 
Alterations in miRNAs system have been associated to generation of several 
diseases such Alzheimer (Satoh et al., 2010), Parkinson (Mena et al., 2010), 
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schizophrenia (Lai et al., 2011) and depression (Saus et al., 2010) indicating that 
miRNAs play a critical role in the enhanced susceptibility for many disorders. 
 
Biogenesis of miRNAs 
 
MiRNAs are derived from precursor molecules, the primary miRNA (pri-
miRNA), that is originated through transcription of miRNA genes by RNA polymerase 
II and III. After transcription there is a processing of pri-miRNA in the nucleus by the 
enzyme Drosha that has like cofactor the DGCR8. This process generates small hairpins 
precursors, the pre-miRNAs, which normally have about 70-110 nucleotides and are 
folded into stem-loop structure. In some cases, a small group of intronic miRNAs, 
called mitrons, is generated from hairpin introns. Their processing don´t involve the 
enzyme Drosha since pre-miRNA is generated through introns by nuclear splicing 
machinery. Formed pre-miRNAs are transported via exportin transfer system to 
cytoplasm where takes place the processing of this molecules by RNA enzyme Dicer 
forming the double-stranded mature small RNA (miRNA/miRNA* duplexes). One the 
molecule of miRNA/miRNA* duplexes is loaded onto an Argonaute homologue protein 
leading to the formation of RNA-induced silencing complex (RISC), whereas the other 
miRNA* strand is degraded (Dwivedi et al.,2011). 
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Fig.5: Ilustration of the synthesis mechanism of miRNAs. miRNA genes are transcribed by RNA 
polymerase II and III originating pri-miRNAs molecules that is processed in the nucleus through the 
enzyme Drosha, generating the pre-miRNAs. Occasionally, intronic miRNAs (mitrons) can be generated 
from hairpin introns. Pre-miRNAs are transported to cytoplasm via exportin where are processed by RNA 
enzyme Dicer forming the double-stranded mature small RNA that posteriorly forms the RISC complex 
(Faller et al., 2008). 
 
The role of miRNAs in brain function  
 
MiRNAs have the capacity of binding to a target site, generally within 3’ 
untranslated region (3’UTR) of an mRNA via base-pairing interactions, inducing their 
degradation or inhibition of translation (Mellios et al., 2008). The inhibitory action of 
miRNAs doesn´t requires a perfect complementary between miRNA-mRNA (Le et al., 
2009); what determines miRNA target specificity seems to be the “seed sequence” of 
the miRNA that is constituted by 6-7 nucleotides (Bushati et al., 2008). Nevertheless, 
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miRNA-mediated regulation is not only due to translation inhibition but may in some 
circumstances act as activators of translation (Krol et al, 2010) or even impair 
transcription through their binding to gene promoters (Younger and Corey, 2011). 
MiRNAs act as a control of protein synthesis and are considered as mediators of 
mRNA turnover and even as a mechanism by which can be determined the amount of 
expressed protein (Calissano et al., 2010). These molecules can effectively regulate the 
amount and timing of the protein expressed and determines the localization of protein 
synthesis. This feature is extremely important to the correct function of the neuronal 
network taking into account that mRNAs are synthesized in the nucleus while gene 
products are often required at the distal ends of dendrites and axons, far away from the 
local of synthesis (Abdelmohsen et al., 2010). The translation of mRNAs stays inhibited 
until neurons stimulation. The regulation of local translation of mRNAs seems to have a 
crucial role in synaptic development and plasticity (Schratt et al., 2006). 
In higher eukaryotes, miRNAs are involved in diverse mechanism of cellular and 
organ physiology such as development, differentiation and diseases (Calissano et al., 
2010), being important genomic regulators. Their expression is temporally and/or 
spatially-dependent during development (Bushati et al., 2008) becoming vital for 
development of nervous system and brain morphology and more specific in neuronal 
differentiation, integrity and plasticity (such as mir-124a and mir-133b), formation of 
synapses in postmitotic neurons (mir-134 and mir-9a) and also circadian rythms (mir-
132 and mir-219) (Bushati et al., 2008; Abdelmohsen et al., 2010; Mellios et al., 2008). 
Indeed, during development the differential expression and activity of miRNAs 
influence the differentiation of different cells in the organism. 
Although the ablations of certain miRNAs doesn´t cause, necessarily, the total 
loss of proper development, it can however lead to significant abnormalities (Andersson 
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et al., 2010; Abdelmohsen et al., 2010). In fact, the level of expression of miRNAs, their 
tissue distribution and the developmental stage in which they are expressed influence 
severally the expression of the target gene products (Abdelmohsen et al., 2010). Defects 
on miRNA system result in a decrease of dendritic complexity, altered spine 
morphology and cognitive defects showing that miRNAs are essential for normal brain 
development and establishment of functional brain connectivity (Magill et al., 2010). 
The consequence of the interaction miRNA-mRNA is determined by a member of 
the argonaute (Ago) protein family, a catalytic component of the RISC complex. 
Depending of the type of argonaute protein and the degree of complementary between 
miRNA and its target sequence, the targeted mRNA may be endonucleolytical cleaved 
and degraded or translational repressed. The repression of the translation might be done 
by deccaping and subsequent exonucleotic degradation (Bushati et al., 2008). One 
single miRNA can target hundreds of mRNAs regulating the expression of several 
transcripts. Therefore, if one miRNA is present at abnormal levels the expression of 
several genes could be severely disturbed (Bushati et al., 2008). This disruption is 
correlated to many diseases since regulation of gene expression is an important aspect 
influencing neuronal plasticity. Moreover, the expression of miRNAs is a critical point 
for the survival of specific types of mature neurons being neuroprotector, preventing or 
slowing the neuronal loss (Bushati et al., 2008). 
 
Impact of miRNAs in neuronal cells 
 
External signals have a significant impact in morphology and function of neurons. 
Such impact can be mediated by posttranscriptional modifications, a vital mechanism 
that controls locally the plasticity of dendrites, axons and synapses. It is likely that some 
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miRNAs can bind to mRNAs coding for neuron-specific proteins, regulating 
mechanisms as synaptic plasticity, neurogenesis, neurite outgrowth and stress responses 
(Abdelmohsen et al., 2010, Dwivedi et al., 2011). Interestingly, turnover of miRNA 
seems to be faster in comparison with other cells what can be a sign of the rapid 
adaptation to neuronal activity mediated by miRNAs (Krol et al., 2010) 
MiRNAs play an important role in synaptic plasticity regulation. They are 
expressed within dendrites regulating the expression of a variety of synaptic mRNAs 
that mediate dendritic growth and keep mRNAs in a dormant state while are transported 
within dendrites to synaptic sites. In the absence of an external stimulus, miRNAs 
inhibit the expression of synaptic proteins controlling the spine development. When trk 
receptor is activated through BDNF the signaling pathway can inactivate the miRNAs 
leading to an enhanced expression of synaptic proteins and, consequently, spine growth 
(Schratt et al., 2006). 
The way by which miRNAS are dendritically localized is not yet understood. A 
possible explanation is that miRNAs in its mature form can arrive in dendrites by 
passive diffusion or can be even possible that pre-miRs are not completely processed in 
cell body but rather appear to be transported to dendrites where are targeted into 
dendritic spines through an interaction with postsynaptic proteins. At this point, DICER 
and RISC components are responsible for processing pre-miRs originating mature 
miRNAs in an activity-dependent manner. MiRNAs are then responsible for local 
regulation of protein translation (Smalheiser et al., 2009). 
Studies in animal models of depression and in human postmortem brain provided 
evidences for the role of miRNAs in psychiatric disorders since their expression appear 
altered in depressive and bipolar patients. Instead, psychoactive drugs are capable of 
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revert the miRNAs expression to normal levels even in brain and blood suggesting that 
their action could be mediated by miRNAs.  
 
BDNF regulation mediated by miRNAs 
 
Pyramidal neurons, the primary source of BDNF in cerebral cortex, show a high 
expression of DICER, a needful enzyme for miRNA biogenesis, as well as RISC 
components. As BDNF exhibits multiple target sites for miRNAs, especially in 3´UTR, 
they can target this neurotrophin reducing its expression (Mellios et al., 2008). This 
feature points to a potential role for miRNAs to differentially regulate BDNF expression 
during development. As previously demonstrated overexpression of a specific miRNA 
can target BDNF and nullify its capacity to stimulate neurite growth. MiRNAs can 
interact at posttranscriptional level of BDNF and interfere with the control of neuronal 
morphology and function (Abdelmohsen et al., 2010). 
The expression regulation of BDNF in dendrites mediated by miRNAs may serve 
as a mechanism to regulate BDNF function in space and time controlling the 
maintenance of dendritic arbor structure or acting as modifying factor to the shape and 
number of dendritic spines. For this reason is important to know exactly how and which 
miRNAs act under BDNF to understand the mechanism of mood disorders and the 
mechanism of action of antidepressant drugs achieving a better therapeutic for these 
disorders. 
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2. AIMS 
 
 
Depression is a mood disorder affecting a crescent number of people worldwide. 
The study of its mechanisms is mandatorily for the therapy of this disorder, representing 
a field of large interest. Recent studies found that different antidepressant drugs can 
activate translation of BDNF protein before the actual rise in the expression of its 
coding mRNA in hippocampus, suggesting that antidepressants may rapidly affect 
posttranscriptional regulation of BDNF (Musazzi et al, 2009). This lack of 
correspondence between BDNF mRNA and protein following antidepressant treatments 
(Jacobsen and Mork, 2004) suggests that antidepressants may have a particularly fast 
effect on posttranscriptional regulation of BDNF. These preliminary results suggest the 
working hypothesis of a role for miRNAs regulation of BDNF in the action of 
antidepressants. For these reasons, this study has the following objectives: 
 
1) To evaluate the role of miRNAs up- or downregulated by antidepressant 
drugs in neuronal morphology, cellular survival and BDNF translation: 
Treatment of adult rats during 2 weeks with antidepressant drugs manufacture by 
Servier (experiments performed by Prof. Maurizio Popoli’s lab at the University of 
Milan) have resulted in the up- or down-regulation of a list of miRNAs. From these 
miRNAs was chosen a group of miRNAs from which was assessed their role in 
neuronal survival and development in vitro of primary cultures of rat hippocampal 
neurons through a morphological assay. Moreover, another goal is the evaluation of 
miRNAs effects on BDNF translation. In this way, we pretend to support the potential 
role of miRNAs in the mechanism of action of the antidepressant drugs. 
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2) To evaluate the functional meaning of 3’UTR long of BDNF mRNA in the 
developmental neuronal morphology: 
As miRNAs target preferentially the 3’UTR of mRNAs it may be possible the 
differential regulation of the two populations of BDNF transcripts, either with long or 
short 3’UTR, by miRNAs.  A previous study in our lab showed that the two populations 
of transcripts are present in the soma and also capable of being targeted to dendrites but 
in different extents, being possible to detect long 3’UTR BDNF transcripts in more 
distal dendritic fields in comparison with 3’UTR short BDNF transcripts (Baj et al., 
2011). For this reason, it is expected that transcripts and consequently its proteins, 
depending of the 3’UTR, play different roles in neurons.  According to these 
observations we had as an objective of this project the evaluation of the role of 3’UTR 
long BDNF transcripts in neuronal and spine morphology through neuronal 
hippocampal neurons from BDNF
lox
 mice, mice truncated for 3’UTR long of BDNF. 
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3. METHODS 
 
 
3.1. Cellular Biology 
 
Culture of hippocampal neurons 
 
Cultures of hippocampal neurons were prepared from postnatal day 1-2 (P1-2) of 
Wistar rat or BDNFlox mice pups. The preparation of the 24-multiwell plates (Sarstedt), 
containing 12mm² coverslips (Sacco) especially for immunofluorescence experiments 
were coated with poly-L-ornithine 100 μg/mL for 20 min, washed once with PBS 
(phosphate buffer solution containing 137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 
1.76mM KH2PO4, pH 7.4) and treated with 0,2% Matrigel ™ (BD Bioscience).  
To extraction of hippocampi from Wistar rat hippocampi were dissected and kept 
in 3mL of cold Hank’s balanced salts solution (NaHCO3 4.2 mM, Hank’s salt powder 
0.952%, HEPES 12mM (4-(2-hydroxyethyl)-1-piperazineethane-sulphonic acid), D-
Glucose 33mM, kinurenic acid 100mM, penicillin 1 mg/mL (Euroclone), and 
streptomycin 1 mg/mL (Euroclone); pH 7.4). The dissected tissue was then digested 
with 500 μL of 0.25% trypsin in native MEM (Minimum Essential Medium + Earle’s 
salts + GlutaMAX™; Euroclone), for 8 min at 37° C. Digestion was blocked with 5.5 
mL of Dulbecco´s modified eagle´s medium (D-MEM- Euroclone) supplemented with 
10% heat inactivated Fetal Bovine Serum (H.I. FBS, Gibco) and 1% 
penicillin/streptomycin (Euroclone EC B3001D 100x) of penicillin-streptomycin 
(Euroclone) and centrifuged at 900 rpm for 5 min at room temperature. The supernatant 
was discarded and the pellet was resuspended in supplemented D-MEM. In order to 
dissociate in single cells, the resuspended pellet was mechanically dissociated and 
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slowly filtered with a sterile 40 µm pore diameter strainer (Sarstedt), removing 
impurities and cellular debris. Finally, cell resuspension was plated onto 24-well plates 
at a cell density of 150-200.000 cells/well.  
To extract hippocampi from BDNFlox mice, was used the procedure previously 
described. The BDNFlox transgenic mice model was kindly provided from Kevin R. 
Jones laboratory and knockout mice for the long 3’UTR (BDNFlox) were obtained by 
crossing heterozygous mice. In this case the hippocampi coming from each mouse were 
dissected and plated separately in order to isolate knockout, wild type and heterozygous 
mice neurons. Both hippocampi of each animal were dissected and kept in 0.5mL of 
cold (4ºC) Halk’s balanced salts solution and digested with 175 μL of 0.25% trypsin in 
native MEM for 8 min at 37° C. Digestion was blocked with 2 mL of D-MEM 
supplemented with 10% heat inactivated Fetal Bovine Serum (H.I. FBS, Gibco) and 1% 
penicillin/streptomycin (Euroclone EC B3001D 100x) and the dissected tissue was then 
centrifuged at 900 rpm for 5 min at room temperature. The pellet was resuspended with 
supplemented D-MEM and filtered through a sterile 40µm pore diameter strainer 
(Sarstedt). Finally, cell resuspension was plated onto 24-well plates achieving a cell 
density of 90.000-130.000 cells/well. 
Cells were maintained in vitro at 37 °C in a 5% CO2-humified incubator. Cell 
number was assessed by a dye exclusion method using Trypan Blue (Fluka). After 1h of 
incubation to permit a proper adhesion, medium was replaced by fresh Neurobasal™ 
Medium (Gibco) supplemented with 2% B-27 supplement (Invitrogen), 0.5% of 1mM 
L-glutamine and 10% penicillin 100U/mL and Streptomycin 100U/mL allowing long 
term growth and viability of postnatal hippocampal neurons and at the same time 
avoiding glia proliferation. Non-neuronal cells on rat hippocampal cultures were further 
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prevented by adding 5.0µM cytosine b-D-arabinofuranoside (ARA-C) from the second 
day in culture. 
 
Neuronal transfection with plasmids 
 
Neurons were transfected with GFP plasmids at 5, 8 and 10 DIV using 
Lipofectamine™ 2000 (Invitrogen) and OptiMEM (Gibco). The transfection mix was 
first prepared separately: one part containing 2µg of GFP and OptiMEM and the other 
with 2µl of Lipofectamine and OptiMEM, in both cases performing a total volume of 
50µl. Each component was gently mixed and incubated at room temperature for 5 min. 
After that they were mixed and incubated for further 20min at RT and in the meanwhile 
the culture medium was replaced for 500 μl new fresh supplemented Neurobasal 
medium. Cells were incubated with the transfection mix (100µl for each coverslip) for 1 
hour at 37° C in a 5% CO2-humified incubator. After 1h of incubation the medium was 
once again replaced for new fresh supplemented Neurobasal and the cells were 
incubated at 37°C until immunofluorescence experiments were performed. 
After 24h (6 and 9 DIV) or 48h (12 DIV) of transfection with GFP, hippocampal 
neurons were blocked. The culture medium was removed and was done a PBS wash, 
followed by fixation with 4% paraformaldehyde (dissolved in PBS pH 7.2) for 20 min 
and a final wash in PBS.   
 
Neuronal transfection with synthetic oligonucleotides  
 
To transfect neurons with BLOCK-iTTM Alexa Fluor® Red Fluorescent Control 
(Invitrogen) the transfection was performed at 5 DIV using Lipofectamine™ 2000 
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(Invitrogen) and OptiMEM (Gibco). The transfection mix was first prepared separately: 
one part containing the required concentration of Block-it and OptiMEM and the other 
with 2µl of transfection reagent (either Lipofectamine™ 2000 or HiPerFect (Qiagen)), 
2µg of GFP and OptiMEM, in both cases performing a total volume of 50µl. In other 
hand, to transfect neurons with miRNAs mimics or inhibitors, both synthesized by 
Qiagen, the transfection was performed at 9 DIV using Lipofectamine™ 2000 
(Invitrogen) and OptiMEM (Gibco). The transfection mix was first prepared separately: 
one part containing 50nM of miRNA mimics or 100nm of miRNA inhibitors and 
OptiMEM and the other with 2µl of Lipofectamine, 2µg of GFP and OptiMEM, in both 
cases performing a total volume of 50µl. 
Each component was gently mixed and incubated at room temperature for 5 min. 
After that they were mixed and incubated for further 20min at RT and in the meanwhile 
the culture medium was replaced for 500 μl new fresh supplemented Neurobasal. Cells 
were incubated with the transfection mix (100µl for each coverslip) for 1 hour at 37° C 
in a 5% CO2-humified incubator. After 1h of incubation the medium was once again 
replaced for new fresh supplemented Neurobasal and the cells were incubated at 37°C 
until immunofluorescence experiments were performed. 
After 24h of neurons transfection with Block-it hippocampal and 72h after 
miRNAs mimics/inhibitors transfection neurons were blocked. The culture medium was 
removed and was done a PBS wash, followed by fixation with 4% paraformaldehyde 
(dissolved in PBS) for 20 min and a final wash in PBS.   
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PC12 cell line experiments 
 
Rat PC12 pheochromocytoma cells (ATCC, Manassas, VA, USA) were seeded in 
25cm2 flasks (Sarstedt) in Roswell Park Memorial Institute (RPMI) 1640 medium (Life 
Technologies) supplemented with 10% of heat-inactivated horse serum (HS) and 5% of 
fetal bovine serum (FBS). The culture was incubated at 37° C in a 5% CO2-humified 
incubator and the medium was renovated every 2-3 days with fresh RPMI supplemented 
medium. When confluence was achieved cells were passage 1:3. 
For cell viability purpose, cells were replaced into a 15mL falcon and centrifuged 
at 900 rpm for 5min at RT and the pellet was resuspended in low-serum RPMI medium 
constituted by 5% of HS and 2% of FBS in order to promote cell attachment. Cells were 
then seeded in 96-well plate previously covered with poly-L-ornithine 100 μg/mL for 
20 min and 0,2% Matrigel ™ (BD Bioscience) in a cell density of 1x106 cells/well 
(Han et al., 2012). Cell number was assessed by a dye exclusion method using Trypan 
Blue (Fluka). Transfection was performed 1 day after plating. The 96-well plate was 
divided in two groups, one transfected at 72h and the other at 48h before doing MTT 
cell viability experiments. Each group contains cells transfected with the miRNAs 
mimics, miRNAs inhibitors, cells treated only with Lipofectamine ™ 2000 (Invitrogen) 
and untreated cells, all conditions in quadruplicate. The transfection mix was first 
prepared separately: one part containing 50nM of miRNA mimics or 100nm of miRNA 
inhibitors and serum-free RPMI medium and the other with 0,4µl of Lipofectamine, 
2µg of GFP and serum-free RPMI medium, in both cases performing a total volume of 
20µl. Each component was gently mixed and incubated at room temperature for 5 min. 
After that they were mixed and incubated for further 20min at RT. Cells were incubated 
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with the transfection mix (20µl for each coverslip) for 72 and 48 hours at 37° C in a 5% 
CO2-humified incubator.  
 
MTT assay viability 
 
After incubation of PC12 with miRNAs mimics or inhibitors the cell viability was 
measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) 
assay. Briefly, MTT (Sigma) was dissolved in PBS 1X to make a 5mg/mL solution and 
10 µl of this solution was added to each well of the 96-well flat bottom plate (Sarstedt) 
and incubated at 37 ◦C in a 5% CO2-humified incubator for 4h. Finished the incubation 
time with MTT the supernatant was carefully removed and the formed formazan 
crystals were dissolved in 100 µl of isopropanol-0,1HCl solution. The plates were then 
analyzed using a Microplate Reader at 560 nm and 600nm. Data was collected from two 
independent experiments. 
 
 
3.2. Molecular Biology 
 
GFP plasmids preparation 
 
In order to prepare GFP plasmids to further cellular transfection, was performed a 
MiniPrep with pGFP-N1 plasmids (Clonetech). Firstly the bacterias were placed into an 
Agar plus ampicilin petri-dish and were incubated at 37ºC O/N. On the day after, were 
picked two of the existing ampicilin-resistent colonies placing them into 5mL of LB 
medium and incubating O/N at 37°C with shaker 200 rpm. The LB medium was then 
 
32 
divided in two 50mL falcons that are subject to miniprep purification. For plasmid 
purification were used the kit of Promega. Cells were centrifuged at 5000g for 10min at 
RT, supernatant were discarded and the pellet resuspended in 3mL of cell resuspension 
solution. Cell lysis solution was added and mixed gently being incubated for 3min. To 
the lisate cells were added neutralization solution that was centrifuge at 15000g for 
15min which originates a pellet of cellular debris that can be discarded. The 
supernatant, with remaining debris, were cleaned through PureYieldTM Clearing 
Columns and a vacuum manifold. PureYieldTM Binding Column was used in order to 
promote the binding of DNA to its membrane. The membrane was washed several times 
and DNA was eluted in 500µl of miliQ water. 
 
Genotyping of BDNF
lox
 mice 
 
The genotypes of BDNFlox mice were identified by PCR. For the extraction of 
genomic DNA from tails each mouse tail was incubated with 300 μL of Extraction 
Buffer (Tris-HCl 10mM pH 8.0, SDS 0.5%, EDTA 0.1M pH 8.0, RNAse 0.2%) at 37 
°C for 1 hour, followed by incubation with 2 μL of Proteinase K (15 mg/mL) at 50 °C 
O/N. On the second day was added 300 μl of Phenol-Chloroform:Isoamyl alcohol (pH 
8.0) to each sample to remove the proteins from the nucleic acids, the samples were 
homogenized in the shaker for 20 minutes. The samples were centrifuged at 12.000 rpm 
for 10 minutes in order to separate the nucleic acids (upper phase) from the denaturated 
proteins (interphase) and the lipids (lower phase). The aqueous phase, containing the 
genomic DNA, was removed to another eppendorf, diluted with 2 volumes of Ethanol 
100%, thoroughly mixed and stored at -80°C for 30 minutes to enable DNA 
precipitation. Finally, all samples were centrifuged at 4°C for 10 minutes at 12.000 rpm 
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and the DNA pellet was resuspended in 100 μl of DNAse - free water. To confirm the 
extraction of genomic DNA was ran in 10% agarose gel at 80V. 
The genotypes were assessed by PCR with specific primers to amplify either the 
long and short 3´UTR of BDNF (reverse primer 5’- ATT ACA AGC AGA TGG GCC 
AC-3’; forward primer 5’- ACC TGG GTA GGA CAA GTT G-3’ (Eurofins MWG 
Operon)). The PCR reactions were performed in a final volume of 20 μl containing 
0,1μL Go Taq Polymerase (Promega Corporation), 4 μl 5X Green Go Taq Buffer , 0,4 
μl dNTPs, 0,8μl MgCl2, 1 μl of each primer, 11,7 μl of  DNAse - free water and 1 μl of 
cDNA added as PCR template. The PCR conditions were set as follow: 5 minutes at 
95°C; 30 cycles of 30 seconds at 95°C, 30 seconds at 58°C, and 30 seconds at 72°C; 10 
min at 72°C. The PCR generates a 250bp product for short 3´UTR and 230bp products 
for long 3´UTR BDNF observed in 15% agarose gel. 
 
Immunocytochemistry for MAP2, SynI and PSD-95 
 
Immunocytochemistry was done in the coverslips previously used for cultures of 
hippocampal neurons at 6, 9 and 12 DIV. The cells were permeabilized with PBS-
Tryton 0,1% for 15 minutes at RT. After permeabilization the coverslips were incubated 
with mix of primary antibody (table 1) containing either 10% of NGS and PBS-Tryton 
0,1% to perform the total volume (70µl for each coverslip) for 1,5 hour at room 
temperature. Cells were then washed several times in PBS in order to remove the 
unbound antibody and were posteriorly incubated for 1h at RT with the secondary 
antibody (table 3). After the incubation the coverslips were once again washed in PBS 
and underwent to a final incubation with Höechst dye solution (0,001%) in order to 
stain all cellular nuclei. Finally, the coverslips were washed with PBS and Milli-Q 
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water and mounted on a glass slide using anti-fade mountant containing Mowiol® 40-
88 (Sigma) to be further analyzed at the fluorescence microscope.  
 
 
Table 1: Primary and secondary antibodies for immunocytochemistry for MAP2, SynI and PS95 
Primary antibody Dilution Host Supplier 
MAP2 1:200 Rabbit polyclonal Santa Cruz Biotechnology 
PSD95 1:250 Mouse monoclonal Millipore 
Syn I 1:200 Rabbit polyclonal Millipore 
 
 
Immunocytochemistry for miRNAs experiments 
 
Immunocytochemistry was done in the coverslips used for cultures of 
hippocampal neuron previously transfected with miRNAs mimics and inhibitors at 12 
DIV. The permeabilization and blocking of the cells was done with 10% NGS, 1% BSA 
and 0,3M glycine- PBS-Tween 0,1% for 45 minutes at RT. After permeabilization was 
done a sequential immunocytochemistry in which coverslips were immuno-stained with 
the primary antibody for BDNF (Sigma) O/N at RT followed by the incubation with the 
primary antibody for the miRNA targets (diluted in PBS-Tryton 0,1%) (Table 2) for 2 
hours at RT (for FMRP, PTEN, MeCP2) or O/N at 4ºC (for LIMK1). Cells were then 
washed several times in PBS in order to remove the unbound antibody and were 
posteriorly incubated for 1h at RT with the secondary antibody (table 3). After the 
incubation the coverslips were washed with PBS, and underwent to a final incubation 
with Höechst dye solution (0,001%) in order to stain all cellular nuclei. Finally, 
coverslips were washed with PBS and Milli-Q water and mounted on a glass slide using 
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anti-fade mountant containing Mowiol® 40-88 (Sigma) to be further analyzed at the 
fluorescence microscope.  
 
Table 2: Primary and secondary antibodies for immunocytochemistry of miRNAs experiments 
miRNA 
Primary antibody 
(αmiRNAs target) 
Dilution Host Supplier 
mir-134 LIMK1 1,5µg/ml Rabbit polyclonal Abcam 
mir-302b FMRP 1:400 Rabbit polyclonal Abcam 
mir-214 
PTEN 1:100 Rabbit polyclonal Abcam 
mir-136 
mir-132 MeCP2 1:150 Mouse monoclonal Genescript 
 
 
Table 3: Secondary antibodies for immunocytochemistry experiments 
Secondary antibody Dilution Fluorophores Supplier 
Anti-Rabbit 1:200 Alexa 568 Invitrogen 
Anti-Mouse 1:200 Alexa 568 Invitrogen 
Anti-mouse 1:200 Alexa 647 Invitrogen 
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3.3. Imaging and Analysis 
 
Fluorescence microscopy 
 
Digital images of GFP-positive neurons either with MAP2 staining or 
immunoreactive for miRNAs targets and at the same time with a nuclear Höechst 
staining were acquired using a Nikon Eclipse E800 epifluorescence microscopy with a 
20X objective and a Nikon DXM1200 camera, paired with ACT-1 software. The 
Höechst staining was visualized with a 488nm fluororophe while MAP2 and miRNAs 
targets were observed with 568nm fluorophore. The pictures were taken in blind. 
 
Confocal microscopy  
 
Images to spines measurements and densytometric analysis were acquired through 
Nikon C1si confocal microscope, containing 457, 477, 488, 514 argon lasers lines and 
561 or 640 nm diode laser. Light was delivered to the sample with an 80/20 reflector. 
The system was operated with a pinhole size of Airy disk (30 nm) (for spines images 
the pinhole was set 60 nm). Electronic zoom was kept at minimum values for 
measurements to reduce potential bleaching. A 60X Oil Apo objective (with 
corresponding NA of 1.4) was used to collect series of optical images at 0.15 μm (for 
spine images) or 0.20 μm (for densitometry) z resolution step size with a corresponding 
voxel size of 75x75x150 nm (X x Y x Z). Images were then processed for z-projection 
by using ImageJ 1.45 (NIH, Bethesda, USA).  
Spines images were collected as 40µm of both proximal and distal fields from the 
neuronal apical dendrite, classification based in well defined parameters (table 4). 
 
37 
Table 4: Parameters defining proximal and distal fields of neurons 
 Proximal field Distal Field 
Diameter (µm) ≥ 2 ≤ 2 
Distance from the soma (µm) ≤ 60 ≥ 70 
 
The set of parameters to acquire the confocal pictures for densytometric analysis 
were maintained exactly the same between pictures from either hippocampal neurons 
under miRNAs mimics and inhibitors action and control.  
 
Cellular viability through Höechst staining 
 
To determine cell density all 12mm
2
 glass coverslips (Sacco) used to neuronal 
culture had been visually divided in four squared fields being collected one picture on 
each one and one more in the periphery of the cross between two fields (Fig.6). With 
this approach the count was done in a reproducible and reliable way. Using the 
multipoint tool of Imagej was possible to count the number of glia cells and neurons 
present in each field taking into account that neurons nuclei have a smaller dimension 
and a stronger and brighter intensity on Höechst staining when compared with glia cells.  
To determine the effect of the treatment with miRNAs mimics/inhibitors in cell 
viability was done the average of the cell density of 3 independent experiments 
comparing each treatment condition with control. 
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Fig.6: Approach to collect pictures from the coverslips used for cultures of hippocampal neurons in order 
to measure cellular viability via Höechst staining. A picture of nuclei demonstrates the differences in the 
size and immunoreactive intensity between neurons and glia cells. 
 
Neuronal morphological analysis 
 
The morphological analysis of hippocampal neurons was focused on four 
different parameters: average of total dendritic length, number of primary dendrites, 
number of secondary dendrites and number of branching points. To reach this aim, the 
morphologic parameters of GFP-positive neurons were measured and quantified by 
tracing all neuronal projections using ImageJ software (NIH, Bethesda, USA). 
In our analysis was measured the length of every dendritic arbors in separately. A 
dendritic arbor was consider as a protrusion emerging from the cell soma with all its 
branches and, so, primary and secondary dendrites. The sum of the dendritic arbors 
length gave us the total dendritic length of the measured neuron. The branching points 
were counted using the Multi-point tool of Imagej. Filopodia protrusions (considered as 
>5 microns-long) were excluded from the total branching point measurements.  
In order to achieve a stronger statistic analysis were measured 44-65 neurons for each 
genotype and time point in the case of BDNFlox mice experiments and about 30 
neurons for each miRNA mimic/ inhibitor. The measurements were done in blind. 
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Polarization analysis  
 
To define the degree of polarization of the neuronal culture we have used the 
method previously described by Horton and Ehlers (Horton and Ehlers, 2006). Briefly, 
was evaluated the contribution of the length of the individual dendrites (Lm) of each 
neuron, considered as the primary dendrite with all its branches, for the total dendritic 
length.  In this way, was done the average of the length of the individual dendrites 
(Lsym) and posteriorly was performed the calculations in the following manner:  
 
Lm /  Lsym = Length of dendrite  /   Total dendritic length  
 
If dendrites were symmetric, the value of the proportion above would be equal:  
Lm =Lsym =1/number of dendrites (Lm/Lsym = 1). 
If dendrites were not symmetric the ratio Lm/Lsym would reflect the degree to 
which dendrites diverge from perfect symmetry (Lm/Lsym = 1). All dendrites that 
presented an Lm/Lsym value above the threshold fixed at 2 have been considered as 
“polarized” dendrites. Finally we have calculated the percentage of neurons that have a 
polarized dendrite, meaning that are polarized neurons. As an alternate measure of 
dendritic polarity we determined the fractional contribution of the primary dendrite (1°), 
of the next longest dendrite (2◦) as well as of the 3° longest and so on until the smallest 
(7°). 
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Spine morphological analysis 
 
Dendritic spines have been classified as Stubby, Thin and Mushroom based on the 
morphological criteria proposed by Harris et al. (Harris et al. 1992) (Figure 2). More 
specific, are defined as “Stubby” the spines in which neck diameter and spine total 
length are comparable; “Thin” if the length of the spine is much greater than both neck 
and head diameters that are both similar and “Mushroom” if the spines have a big head 
diameter and a small neck. Following a visual classification based on known 
morphological criteria, the straight line tool of ImageJ software was used to measure the 
spine length, traced from the edge of the dendrite to its farthest point, the spine head 
diameter as well as the dendrite length (Fig.14). The spine density was reached through 
the quotient between the number of spines found in the proximal or distal field and the 
dendritic length (40µm). 
 
Fig.7: Criteria taking into account for spines classification performed by the operator. “Stubby” spines 
have neck diameter and spine total length comparable; “Thin” if the length of the spine is much greater 
than both neck and head diameters that are both similar and “Mushroom” if the spines have a big head 
diameter and a small neck. (Harris et al., 1992; Rodriguez et al., 2008). 
 
41 
 
 
 
 
 
 
 
Fig.8: Approach to measurement of spines in order to do a good analysis of spine morphology between 
different conditions of development of the culture of hippocampal neurons (Smith et al. 2009). 
 
Co-localization of Syn-I and PSD-95 
 
The degree of Synapsin-1 and PSD-95 co-localization had been evaluated starting 
from confocal images of both proximal and distal fields of the apical dendrites. In 
particular Alexa-586-labeled secondary antibody (bound to Synapsin-1 primary 
antibody) was visualized using a 561 nm diode laser while PDS-95 signal was detected 
by excitation of the Alexa-647 secondary antibody through a 640 nm diode laser. 
Moreover, to avoid any possible cross-talk phenomena among fluorophores, all images 
were collected using the method of sequential line scanning. The final quantification of 
colocalized pixel was performed using the software Imaris (Bitplane) and its 
colocalization module. The software was used with default setting with the addition of 
an automatic threshold for pixel intensity calculated on real point spread function for 
our microscopy and optics. The colocalization was quantified as amount of fluorescence 
collected from each pixel stained (over the threshold) for both protein targets. 
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Bioinformatic analysis of miRNAs targets 
 
The search of targets for miRNAs was performed with miRWalk database that 
provides information on the predicted and validated targets and their binding sites in 
human, rat and mouse organisms. The predicted targets are achieved through the study 
of the possible interactions between miRNAs and target genes whereas the validated 
targets module provide information about experimentally verified miRNA interaction, 
both of them presenting the interaction sites in complete sequence (promoter, 5' UTR, 
CDS and 3' UTR) of all known genes. These two modules have their last update on 
March 2011, crucial for reliable results. The information of the possible interactions is 
gave by 9 different algorithms (miRWalk, Diana-microT, miRanda, miRDB, PICTAR, 
PITA, RNA22, RNAhybrid and Targetscan) which present for each miRNA or gene 
target a range information such as: number of algorithms that recognize a specific 
complementary between miRNA-target, P-value, number of nucleotides of miRNA seed 
sequence, position of the binding site, between others. 
Finished the analysis of the validated targets for the miRNAs (mir-132, mir-134, 
mir-302b, mir-214), among the total number of gene targets they were subject to a 
selection taking into account important aspects such as the presence of the target protein 
in neurons and implication in crucial pathways of neuron development. For the analysis 
of the predicted miRNAs that have as target BDNF, among the wide range of miRs, 
were selected only the miRs that make part of the group that are in agreement with the 
following parameters: recognition of the interaction miRNA-BDNF for at least 2 
algorithms, miRNA seed sequence constituted for 8 nucleotides minimum, binding-site 
in the 3´UTR of BDNF transcript and a validated target expressed in neurons.  
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Densitometric analysis 
 
Evaluation of the effect of miRNAs mimic or inhibitors on the expression level of 
the targeted protein was performed on confocal pictures densitometric analysis. Within 
experiments all conditions, including illumination intensity and photomultiplier gains 
were kept constant. For proteins that are only expressed in the soma the densitometric 
analysis focused precisely in this area while with proteins expressed in the total neurons 
were also analyzed secondary branching points. The densitometry of the positive-signal 
for the target protein was achieved through Measure Stack plugin of ImageJ Software 
and the chosen neuron area to further analysis were every time the same between 
neurons in the same picture. The densitometry of each neuron is reached through the 
sum of the immunoreactivity of all neuron stacks. As densitometric value for each 
treatment, to further comparison between miRNAs mimics and inhibitors effects on 
neurons, was calculated the mean fluorescence intensity for each group. To quantify 
experimental data obtained from separate days, data were normalized relative to mean 
fluorescence intensity in control neurons. Moreover, were also normalized the collected 
data with mean fluorescence intensity of backgroung in each picture. To achieve a 
strong statistic meaning were analyzed 25 neurons for each miRNA mimics, inhibitors 
and controls. 
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Fig.9: Densitometric analysis to quantification of protein expression level. Using ImageJ Software the 
densitometry of a specific area of the neuron is measure and normalized with the background. 
 
Data representation and statistic analysis 
 
The results were represented as mean of all measurements with corresponding 
standard errors (SE). All graphs and statistical analysis were performed with Sigma Plot 
11 Software (Systat Software, Inc). 
Statistical significance among groups was evaluated performing both t-test, and 
One Way ANOVA followed by an all pairwise multiple comparison procedure with 
Holm-Sidak’s method where ***, P ≤0.001, **, P≤0.01, and, *, P≤0.5. 
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4. RESULTS 
 
 
4.1. Role of miRNAs up- or downregulated by antidepressant drugs in neuronal 
morphology, survival and BDNF translation 
 
Recently, a growing number of evidence point for the involvement of miRNAs 
in the mechanism of antidepressant drugs (Zhou et al., 2009; Baudry et al., 2010; 
Angelucci et al., 2011; He et al.; 2012; Smalheiser et al., 2012). To evaluate the effects 
of antidepressant treatment on miRNAs expression, adult rats were treated with 
different antidepressant drugs (agomelatine, fluoxetine and desipramine) during two 
weeks. The RNA extraction from hippocampus of rats treated with antidepressants or 
untreated was processed and analyzed using microarrays technology to evaluate the 
miRNAs level expression. Further statistical analysis showed significant alteration of 
the expression level of certain miRNAs upon treatment. Antidepressant treatment and 
microarrays experiments were performed by our collaborators Prof. Maurizio Popoli´s 
lab at the University of Milan (www.unimi.it). From the list of miRNAs that were 
altered upon treatment we have chosen three that presented the higher or the lowest fold 
change when compared with control levels obtained from untreated rats to further 
screening in vitro (Table 5). 
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Table 5: MiRNAs compiled from microarray analysis from RNA of adult rats treated with 
different antidepressant drugs. 
miRNA Antidepressant drug Fold Change 
mmu-mir-136 Agomelatine 0.48 
mmu-mir-302b 
Fluoxetine 3.11 
Desipramine 3.47 
hsa-mir-214 
Fluoxetine 0.44 
Desipramine 0.56 
 
 
To evaluate miRNAs effects on neuronal morphology, survival and BDNF 
translation the required techniques were performed on postnatal hippocampal neurons 
from rat Wistar. In order to address these goals the neurons were treated either with 
miRNAs mimics or miRNAs inhibitors oligonucleotides (Qiagen) so as to acquired 
similar conditions to those obtained with up- or downregulation of endogenous 
miRNAs and elucidate the biological role of the miRNAs on neuronal function. 
 
Optimization of neuronal transfection with synthetic oligonucleotides 
 
In the absence of a well establish protocol to neuronal transfection with synthetic 
oligonucleotides, it was necessary to set up the exact conditions to do it, not only in a 
way that guarantees the neuronal transfection with miRs but also to ensure that they are 
actually acting and producing a similar decrease or increase on gene expression.  
Since miRs mimics/inhibitors oligonucleotides are not fluorescently labeled, being 
impossible to know their exact localization into the culture and verify the neuronal 
 
47 
transfection with these oligonucleotides, was used the BLOCK-iT (Invitrogen), a red-
labeled dsRNA oligomer with similar length, charge and configuration to miRs. The 
sequence of BLOCK-iT is not homologous to any known gene avoiding the possibility 
of BLOCK-iT-mediated effects by silencing neuronal proteins, serving as a control of 
transfection efficiency facilitating assessment and optimization of oligonucleotides 
delivery into cells. In this way, the transfection of hippocampal neurons at DIV 5 and 
DIV 11 was done with different concentrations of BLOCK-iT (5nM, 25nM, 50nM and 
100nM) using either Lipofectamine (Invitrogen) transfection reagent or Hiperfect 
(Qiagen), a transfection reagent especially design to delivery siRNA or miRNA. 
Additionally, hippocampal neurons were also co-transfected with GFP plasmids to 
allow the visualization of the entire cell morphology in green to further morphological 
analysis. The transfected coverslips were fixed 24h after transfection using PFA 4% and 
were immuno-stained using antibody against MAP2 proteins and even with Hoechst 
staining for cellular nuclei (see methods). All images were obtained by choosing 5 
fields of the coverslips as described at methods (see Fig.6) using the 20X objective of 
epifluorescence microscope. The transfection efficiency was obtained through the ratio 
between BLOCK-iT-positive cells (nuclear red-labeled) and the total number of neurons 
in culture. This measurement was performed using multipoint tool of Imagej Software 
making the discrimination between neurons and glia cells (see methods, Fig.6). 
BLOCK-iT-positive neurons were present in a really small number when 
transfected with the lower concentration of BLOCK-iT, recommended by the supplier, 
being reached less than 0,1% with Hiperfect transfectant and about 2% with 
Lipofectamine2000 of tranfection efficiency. The transfection efficiency started to be 
higher from 25nM of BLOCK-iT; nevertheless, this increase was merely observed with 
Lipofectamine2000 reagent rather than Hiperfect, which seems not to work properly. 
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For this reason, transfection with the higher concentrations of BLOCK-iT (50nM and 
100nM) was just performed with Lipofectamine reagent. Surprisingly, transfection 
efficiency for these concentrations reached extremely high values: 88,9% and 96,7% of 
neurons are positive for BLOCK-it when it´s used 50nM or 100nM of this 
oligonucleotide, respectively. Simultaneously, the cell density upon transfection with 
BLOCK-iT was measured in order to verify if transfection with such high concentration 
of synthetic oligonucleotide is toxic to neuronal cells. To measure the cell density 
images of 5 fields of the coverslips were taken as described at methods (see Fig.6) using 
the 20X objective of the epifluorescence microscope followed by the count of the cell 
density of two different cultures. Cell density of all experiments did not suffer 
significant changes when compared with untreated neurons, which means that 
transfection with BLOCK-iT doesn´t have a toxic effect (Fig,10).   
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Fig.10: Optimization of hippocampal neuronal transfection with BLOCK-iTTM. (A) Example of a 
BLOCK-iT-positive neuron. A panel of a hippocampal neuron at 6 DIV co-transfected with pGFP and 
50nM BLOCK-iT (nuclear red-stained) is presented using Lipofectamine transfection reagent and nuclear 
stained with Hoëchst. (B)  Cell density, measured for each condition, shows no toxic effect of BLOCK-iT 
to any concentration. (C) Transfection efficiency obtained with transfection of rat hippocampal neurons 
with different concentrations of BLOCK-iT (5nM, 25nM, 50nM and 100nM) using either Lipofectamine 
or Hiperfect transfection reagents shows the elevated transfection efficiency for the highest 
concentrations of BLOCK-iT (50 and 100nM) when transfected with Lipofectamine 2000.  Results 
represent quantification of two independent experiments and are expressed as percentage (mean ± St 
Dev). 
 
 
Taking into account that the concentration of BLOCK-iT should be extrapolated 
to those for miRs mimics and inhibitors to posterior morphological measurements is 
crucial that such concentration achieve real high transfection efficiency, in order to be 
sure that our measurements represent reliable results. Since information provided by 
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supplier refers that concentration used to achieve an optimal activity for miRs inhibitors 
should be higher to those used for miRs mimics we decided to use miRs mimics at 
50nM and inhibitors at 100nM.  
 
Evaluation of miRNA activity 
 
After choosing the appropriate oligonucleotides concentration to guarantee 
neuronal transfection was further evaluated their activity. Since miRNAs bind to mRNA 
target mediating mRNA degradation or inhibition of translation (Lang et al., 2012), their 
activity can be correlated with the expression level of the target protein. Thus, is 
essential the quantification of their expression after transfection with miRNAs mimics 
or inhibitors, comparing it with basal levels obtained from neurons control. 
With this purpose, it was mandatory the search for validated mRNA targets of 
mir-124, mir-302b and mir-136. In addition to the miRNAs modulated by 
antidepressants, we have chosen two miRNAs previously described in literature as 
positive (mir-132) (Vo et al., 2005; Magill et al., 2010) and negative (mir-134) (Shratt 
et al., 2006) modulators of neuronal morphology. Search of miRNAs targets was 
performed with miRWalk database that comprises information of experimentally 
validated targets. This module had its last update on March 2011, crucial for reliable 
results. An extensive list of validated targets was provided by miRWalk database being 
chosen the target proteins involved in crucial pathways of neuronal development or 
connectivity (Table 6).  
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Table 6: List of miRNAs and their validated gene targets provided by miRWalk Database. 
miRNAs Target Biological processes References 
mir-302b FMRP 
mRNA transport and translation 
Synaptic plasticity 
Kao et al., 2010 
Huber et al., 2002 
mir-214 
PTEN 
Adult neurogenesis 
Synaptic plasticity 
Amiri et al., 2012 
Blair et al., 2012 
Sperow et al., 2012 
Yang et al., 2008. mir-136 
mir-132 MeCP2 Transcription regulation Su et al., 2012 
mir-134 Limk1 
Regulator of actin dynamics 
Synaptic stability 
Foletta et al., 2004 
Eaton et al., 2005 
 
 
Another important aspect to take into account was the optimal time of 
incubation with miRNAs mimics/inhibitors in order to achieve the maximum activity of 
these oligonucleotides. Since previous works carrying out experiments with miRNAs 
with similar purposes to ours used 72h of incubation with miRNAs (Shratt et al., 2006) 
and information provided by supplier indicate it as a time in which miRNAs are stable 
and active, we have decided to do the experiments with 72h of incubation with miRs. In 
this manner, rat hippocampal neurons at 3 and 9 DIV were transfected with 50nM miRs 
mimics or 100nM miRs inhibitors using Lipofectamine2000 reagent and were fixed 72h 
after transfection using PFA 4%. In this way, it is possible to evaluate the miRNAs 
effect at 6 and 13 DIV, in young and mature neuronal stage (Dotti et al., 1988). After 
fixation, the coverslips were immuno-stained with the antibody against the 
corresponding protein target and also for cellular nuclei with Hoechst staining.  
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At this point, two kinds of measurements were made: one to evaluate the 
miRNA-targeted protein expression and another to evaluate neuronal survival. To 
measure the cell density, images of 5 fields of the coverslips were taken as described 
before and was done the count of the cell density of two different cultures treated either 
with miRs mimics or inhibitors. No significant changes were observed in the cell 
density between the control, cells treated with miRs mimics or with miRs inhibitors and 
cell density was between 130.000-150.000 cells/coverslip, what is important to show 
that the transfection treatment is not promoting cell death. In regard to the expression of 
the proteins targeted by miRNAs we have collected images with confocal microscope 
for neuronal densitometric analysis (see methods). Densitometric analysis allow us to 
determine the difference in the protein expression between control, miRs mimics and 
miRs inhibitors groups by quantification of protein fluorescence intensity. As the 
chosen miRNAs target proteins expressed at the soma was done the densitometric 
analysis on this specific area (see methods, Fig.9). Fluorescence intensity was measured 
through ROI Manager of ImageJ Software which analyzes the mean grey value of each 
stack of the chosen area. The mean grey value for each neuron was everytime 
normalized through the subtraction of the mean grey value of the background for each 
field, giving the true protein signal. Densitometric analysis showed a general decrease 
(between 17 and 36%) and increase (between 14 and 26%) on the protein expression 
when it was done the transfection with miRNAs mimics and inhibitors, respectively 
(Fig.11). Although there is not significant variances, such alterations on protein 
expression is reproducible for all miRNAs. 
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Fig.11: Protein expression 
quantification after transfection 
with miRNAs mimics and 
inhibitors. Protein expression 
levels quantified by 
densitometric analysis of the 
nuclear soma of hippocampal 
neurons incubated during 72h 
with mir-132 (A), mir-134 (B),  
mir-302b (C), mir-214 (D) and 
mir-136 (E) shows a general 
increase and a decrease on the 
expression of the protein target 
when it is used miRNAs mimics 
and inhibitors, respectively. Data 
was collected from 25 neurons. 
(F) Cell density of hippocampal 
neuronal cultures did not suffer 
significant changes with the 
miRNAs transfection implying 
that there is not a toxic. 
 
 
 
 
Finished the optimization of the neuronal transfection conditions with miRNAs 
oligonucleotides we have started the functional screening in vitro of the miRNAs effects 
on neuronal morphology, survival and BDNF translation. 
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Effect of miRNAs on neuronal morphology 
 
As miRNAs can target many genes involved in the establishment of neuronal 
morphology we had focus our attention on neuronal and spine morphology of 
hippocampal neurons treated with miRNAs mimics or inhibitors. Therefore, was 
measured the neuronal total dendritic length (µm) and the number of primary and 
secondary dendrites (see methods). These analyzes were performed through co-
transfection of rat hippocampal neurons at 3 and 9 DIV with miRNAs mimics/inhibitors 
and GFP, in which miRNAs were incubated for 72h. At 6 and 12 DIV the coverslips 
were fixed with PFA 4% and images were collected with epifluorescence microscope 
and further analyzed with NeuronJ plugin of ImageJ software. The neuronal 
morphology was done in blind and in the most conservative manner possible. The 
primary dendrite was measured from its inception (the point of intersection between the 
primary dendrite and the soma) to its end, the farthest point of the dendrite. Secondary 
dendrites were measured in the same way, from its beginning (the point of intersect 
between the secondary and primary dendrites) and its end. To define the total dendritic 
length (µm) of each neuron was done the sum of the length of all dendrites. Finally, the 
total dendritic length for each miRNA mimic/inhibitor was presented as mean ± St 
Error. Statistical analysis with t-test and one way ANOVA were performed to verify if 
there were significant differences between miRNA treatments and control.  
Neuronal morphology at 6 DIV did not change with the up or down-regulation of 
miRNAs, instead, at 12 DIV we can observe a statistically significant variance in the 
dendritic length of both mir-132 and -134. With miRs mimics was observed an increase 
on the total dendritic length for the mir-132 and a decrease for the mir-134. However, 
any significant changes were observed in the number of primary and secondary 
dendrites.  
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Fig.12: Effect of miRNAs expression in the morphology of hippocampal neuronal cultures. Total 
dendritic length (µm), primary and secondary dendrites are represented as mean ± St error. Quantification 
of total dendritic length and branches was made from at least 20 neurons. The statistical significance 
between mimics, inhibitors and controls neurons was evaluated using t-test where ***, P ≤0.001, **, 
P≤0.01, and, *, P≤0.05. 
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Effect of miRNAs in cellular viability 
 
Previous studies have demonstrated the role of miRNAs on cellular viability 
either by causing cell death (Fang et al., 2012) or cell proliferation (Zhong et al., 2012). 
In this way, we have tested the effects of the miRNAs on the viability of PC12 cells 
(pheochromocytoma cells), proliferative cells that allow us to quantify both cell death 
and cell proliferation ratios. PC12 cells grew in RPMI medium supplemented with 10% 
of horse serum and 5% of FBS in 25cm2 flasks and medium was replaced every 2-3 
days in order to provide new nutrients to cells. Reaching a high cell density, PC12 cells 
were seeded into 96-well plate in RPMI medium low supplemented (5% HS and 2% 
FBS) which induces cell attachment at a cell density of 1 x 10
6
. After one day, cells 
were transfected with 50nM of miRs mimics and 100nM of miRs inhibitors as 
previously described (see methods). Evaluation of miRNAs effect on cellular viability 
was carried out at two different times of incubation with the oligonucleotides, 48 and 
72h. After incubation was performed the MTT assay, a colorimetric assay that permits 
to evaluate the activity of the reductase enzymes that convert MTT dye into formazan 
crystals in living cells (Tim Mosmann, 1983). Absorbance of the samples was measured 
using a plate reader at 560 and 600nm. Statistical analysis shows a significant decrease 
on the cellular viability at 48h of incubation with the miRNAs mimics/inhibitors of 
about 50% which demonstrates the cytotoxicity of the treatment for this cell line; 
however, the cellular viability shows an increase at 72h in comparison with the previous 
results and in some cases cellular viability is practically restored (Fig.13). 
Unfortunately, MTT assay doesn´t show any specific effect for the miRs mimics and 
inhibitors but instead a general cytotoxicity effect for the PC12 cells transfection with 
miRNAs oligonuceotides. 
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Fig.13: MTT assay performed to evaluate the effects of miRNAs on cellular viability. Two times of 
incubation with the miRNAs mimics and inhibitors were used (48 and 72h) and absorbance was read at 
560 and 600nm. No specific effect on cellular viability is observed but rather the cytotoxicity of the 
treatment. Data were collected from 2 independent experiments and are represented as mean ± St Error. 
 
Effect of miRNAs on BDNF translation 
 
Besides evaluation of miRNAs effects on neuronal morphology and cellular 
viability, we have even evaluated their effects on BDNF translation. Many miRNAs 
target BDNF inducing its expression decrease, which may explain the neuronal 
plasticity impairment observed in depressed patients (Blugeot et al., 2011). Therefore, is 
important to understand what kind of consequence the miRNAs modulated by 
antidepressant drugs have on BDNF mRNA. In this way, rat hippocampal neurons 
transfected at 3 and 9 DIV and incubated for 72h with miRs mimics/inhibitors were 
immuno-stained with antibody against BDNF (Sigma). After that, images collected with 
60X objective of confocal microscope were analyzed with Imagej Software to do 
densitometric analysis to quantify fluorescence intensity of BDNF protein in control, 
miRs mimics and miRs inhibitors groups. Quantification of BDNF protein was done in 
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neuronal soma of hippocampal neurons as described at methods. In general, BDNF 
expression after incubation with miRNAs during 72h does not change significantly. 
Nevertheless, changes verified in the BDNF expression tends to follow a similar 
behavior both in soma and dendrites since it is observed that a decrease on the protein 
level in the soma as a correspondence decrease on the protein level on the dendrites. An 
important observation is that protein levels for miR-134, a modulator of the BDNF 
expression, demonstrate an alteration in its expression level, being verified an increase 
with the miRs mimics and a decrease with miRs inhibitors (Fig.13). 
 
Fig.14: Effect of miRNAs on BDNF expression levels. Densitometric analysis represented as relative 
intensity of the protein expression from the soma (A) and dendrites (B) of hippocampal neurons 
transfected with miRNAs oligonucleotides does not show significant variances in the BDNF expression 
levels; however, for miR-134 it is observed a tendence for the increase and decrease of BDNF expression 
caused by miRNAs inhibitors and mimics, respectively.  
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Bioinformatic analysis for miRNAs binding sites into BDNF gene  
 
MiRNAs can modulate the BDNF protein expression directly by targeting its gene 
or indirectly by targeting other genes involved in its transcription or translation 
mechanisms. The knowledge of miRNAs targets is essential to understand which 
mediators are involved in the mechanism of many diseases. As mentioned above, 
BDNF is decreased in depressed patients (Blugeot et al., 2011) being its expression 
level restored when it´s administrated antidepressant drugs (Ubhi et al., 2012), thus, it is 
important to know which miRNAs can target BDNF regulating its expression in the 
brain. Bioinformatic analysis emerges in this field as an important tool to search for 
miRNAs that have as target the BDNF mRNA. To obtain this information, the search 
was done through miRWalk database, which provided not only the miRNAs 
experimentally validated to target BDNF mRNA but also the miRNAs predicted to 
target it. Predicted targets are achieved through the study of the possible interactions 
between miRNAs and all known genes, being provided the interaction sites in the 
complete sequence of the gene (promoter, 5' UTR, CDS and 3' UTR). The possible 
miRNA-mRNA interactions are given by 9 different algorithms (miRWalk, Diana-
microT, miRanda, miRDB, PICTAR, PITA, RNA22, RNAhybrid and Targetscan), 
which ensure a powerfull analysis. For each miRNA or gene target is provided a wide 
range of information is provided, such as: number of algorithms that recognize a 
specific complementary between miRNA-target, P-value of such match, number of 
nucleotides of miRNA seed sequence, position of the binding site, between others. 
From the extensive list of predicted miRNAs to target BDNF was done the selection of 
the miRs in agreement with the following parameters: recognition of the interaction 
miRNA-mRNA for at least 2 algorithms and miRNA seed sequence of at least 8 
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nucleotides. The binding sites of miRNAs were given for the BDNF transcript variant 1 
of Human, the longest transcript of the BDNF gene.  
Regarding validated BDNF-target miRNAs, the list of miRs was once again 
achieved by miRWalk database. Nevertheless, their precise binding sites were obtained 
by microRNA.org, a database that allowed us to obtain the binding site and its precise 
aligment between miRNA and target mRNA. The information collected by these 
miRNAs databases concerning the miRNAs targeting BDNF (either already validated or 
merely predicted) was summarized both in the figure 14 and the table 7. Among the 
validated and putative miRNAs to target BDNF gene is visible the higher affinity of 
miRNAs for the 3’ UTR.  
 
 
Fig.15: miRNAs binding sites into the Human BDNF transcript variant 1. Bioinformatic analysis for 
miRNAs binding sites shows a strong interaction between miRNA and BDNF mRNA in the 3´UTR. In 
the upper part is shown the binding sites for the experimentally validated miRNAs is shown while in the 
lower part are shown the miRNAs predicted to target BDNF. Repetition of microRNAs represents the 
multiple binding sites of the miRNAs. Notice that highlighted miRNAs are those evaluated in this study. 
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Table 7: Number of miRNAs targeting a specific region of BDNF gene. 
 5’UTR CDS 
3’UTR 
Short Long 
Predicted 7 10 7 39 
Validated 0 0 10 18 
Total 7 10 17 57 
 
 
 
The preferential capacity of miRNAs to bind to the BDNF mRNA 3’UTR, 
especially its long portion, may have important consequences in the expression level of 
the two populations of BDNF transcripts either with the short or long 3’UTR. For this 
reason, it was important to understand the role of these two types of transcripts. 
 
 
 
4.2. Role of 3’UTR long of BDNF mRNA in neurons 
 
BDNF gene has a complex transcription mechanism, which can originate 
different isoforms of BDNF through alternative splicing (Aid et al., 2007). Likewise, 
alternative polyadenilation creates two populations of transcripts that carry either short 
or long 3’UTR. The structural and functional meaning on neuronal population of such 
transcripts is still a topic in debate. To determine their function, a mice strain 
specifically originated to lack the long 3’UTR- BDNFlox mice was created. The 
absence of the 3’UTR long has allowed us to evaluate its involvement in the neuronal 
and spine morphology and plasticity. 
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The neuronal morphology and plasticity was assessed through neuronal 
hippocampal neurons from BDNF
lox/lox 
(referred as LOX), BDNF
lox/+ 
(referred as HET) 
and BDNF
+/+
 (WT) mice, maintained in culture up to 6, 9 and 12 DIV. In this way it´s 
possible to study three different neuronal stages: young, adult and matured neurons 
(Baj, Patrizio and Tongiorgi, in Submission). Hippocampal neurons were transfected at 
5, 8 and 10 DIV being fixated at 6, 9 and 12 DIV in PFA 4%. Subsequently, coverslips 
were immuno-stained with antibody against MAP2 and stained with Höechst. Images 
were collected in epifluorescence microscope and neuronal measurements were 
performed with NeuronJ plugin of the Imagej Software. For neuronal morphology was 
measured the length of the primary and secondary dendrites to achieve the total 
dendritic length; moreover, also the number of primary and secondary dendrites as well 
as branching points was count for each genotype and time point. Statistical analysis 
showed a significant reduction on the total dendritic length (µm) of the BDNFlox mice 
at 6 and 12 DIV in comparison to heterozygous or WT mice, that don´t have any 
difference between them. Nevertheless, the number of primary and secondary dendrites 
and also branching points do not suffer significant changes (Fig.14). 
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Fig.16: Hippocampal neurons of BDNFlox mice have a lower dendritic length but a normal number of 
branches. Representative images of hippocampal GFP-positive neurons at 6 (A), 9 (B) and 12 (C) DIV. 
The images were taken through epifluorescence microscope using a 20X objective and analyzed with 
ImageJ Software to quantify neuronal morphology. Total dendritic length (D), primary dendrites (E), 
secondary dendrites (F) and branching points (G) of hippocampal neurons from BDNF
lox
 (lox), BDNF
lox/+ 
(het) and BDNF
+/+
 (wt) mice are represented as mean ± St error. Quantification of total dendritic length 
and branches was made from 44-56 neurons and at least 3 cultures for each time point and genotype. The 
statistical significance between the three genotypes was evaluated using t-test where ***, P ≤0.001, **, 
P≤0.01, and, *, P≤0.05. 
 
 
Measurements of neuronal and spine morphology were done in pyramidal 
hippocampal neurons, neurons characterized by their asymmetric dendritic arbor 
(Horton et al., 2006). For this reason, we have evaluated the polarization of the 
hippocampal neurons of each genotype in order to see if there is any change in the 
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polarization process. Neurons are considered as polarized when the apical dendrite has 
at least the double of the length of the other dendrites. Through this evaluation we have 
determined the percentage of polarized neurons and the contribution of each dendritic 
arbor to the total dendritic length using the Horton’s method (Horton and Ehlers 2006) 
(see Methods). Any change is visible among the three genotypes, since the percentage 
of polarization and dendritic rank maintain in the same range of values for all of them.  
 
 
Fig.17: Polarity of hippocampal neurons in vitro. Percentage of polarized neurons (mean ± St error) do 
not shows significant differences between the three genotypes (A). The contribution of each dendrite for 
the total dendritic length (expressed as ratio Lm/Lsym) at both 6 (B) and 12 (C) DIV is comparable 
among the three genotypes of mice. Dendrites are ranked longest to shortest. Data collected from 44 up to 
65 neurons. The statistical significance among the three genotypes was evaluated using One Way 
ANOVA.  
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Afterwards, the spine morphology of each genotype was evaluated. Pictures of 
the spines were collected by GFP- positive neurons with 60X objective of confocal 
microscope. From each neuron we took two fields of 40µm in proximal and distal fields 
of the apical dendrite (see methods). Images were analyzed with ImageJ Software in 
order to achieve the number of stubby, thin and mushroom as well as the spine density 
(represented as number of spines per 10µm) present in each genotype.  Concerning the 
spine density, in both genotypes was verified an increase on the spine number of both 
proximal and distal fields of the neurons as they grew up. BDNF
lox
 mice tend to have a 
lower spine density, especially at later development stages. However, such difference is 
not significant. The qualitative analysis of the spine types which discriminate stubby, 
thin and mushroom spines observed in the apical dendrite points to morphological 
changes in the spines. There is a decrease in the stubby and an increase in the thin and 
mushroom spines number with the neuronal development. Among the three genotypes, 
changes in the proximal fields were observed; nevertheless, truncation of the long 
3’UTR had a negative impact on the final stages of the spine maturation since BDNFlox 
mice have a decrease on the number of mushroom spines in the distal fields of matured 
neurons. 
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Fig.18: Spine maturation of hippocampal neurons from BDNFlox mice is impaired. (A) Representative 
confocal images of 40µm fields of distal fields of the apical dendrite of 12 DIV hippocampal neurons 
from BDNF
lox
, BDNF
lox/+ 
(HET) and BDNF
+/+
 (WT). (B) No significant changes were observed in the 
spine density, represented as the number of spines per 10µm, among the three genotypes. The percentage 
of spine types (stubby, thin and mushroom) in proximal fields (C) and distal fields (D) show a difference 
only in the percentage of mushrooms spines present in the distal fields of matured neurons. Measures are 
presented as mean + St Errors and statistical analysis were obtained using One Way ANOVA where ***, 
P ≤0.001, **, P≤0.01, and, *, P≤0.05. 
 
 
To evaluate the maturation of spines present in hippocampal neurons during 
neuronal development we have quantified the colocalization of Syn-I and PSD-95. With 
this purpose, cells were immuno-stained both against PDS-95 and SYN-1 and images 
were collected by confocal microscope. The quantification of the colocalization was 
performed following a threshold setting (see methods). Data were analyzed as the 
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percentage of PDS-95 signal that co-localizes together with Synapsin-1, regarding to the 
total output of PSD-95 signal. Following a statistical analysis using One Way ANOVA 
and all pairwise multiple comparison test, significant differences were observed 
between BDNF
lox
 and WT mice at the three time points. The results show a decrease of 
approximately 40% in the colocalization PSD-95/SynI in hippocampal neurons of 
BDNF
lox
 mice comparing with WT mice (Fig.19). 
 
 
 
Fig.19: Colocalization of PSD-95 and Syn I. Quantification of the degree of the colocalization 
(represented as the percentage of colocalized PSD-95 with respect to the total PSD-95) shows significant 
variance between the BDNFlox and WT mice for all time points. Statistical analysis was done with One 
Way ANOVA followed by an all pairwise multiple comparison procedure with Holm-Sidak’s method 
where ***, P ≤0.001, **, P≤0.01, and, *, P≤0.05. 
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5. DISCUSSION 
 
 
Depression is a mood disorder that affects proximately 121 milion people 
worldwide and represents one of the most common disorders to disability (World 
Health Organization). Many factors are involved in the onset of this disorder including 
dysregulation of miRNAs signaling (Saus et al., 2010). Since miRNAs can target and 
inhibit the expression of many genes, regulating a large spectrum of biologic processes, 
defects on their activity may have undesirable effects on brain function. Diverse types 
of antidepressants can in turn modulate miRNAs expression. Experiments performed by 
our collaborators at the University of Milan have shown that antidepressant drugs 
administrated in adult rats for two weeks modulate the expression of several miRNAs, 
either by promoting their increase or decrease. Thus, the functional meaning of the 
alterations in the miRNAs expression pattern caused by antidepressant drugs emerges as 
an important field of research.  
In order to understand the role of miRNAs modulated by antidepressants in the 
neuronal cells and, consequently, in  brain function,  three miRNAs were selected from 
the list of the miRNAs compiled by microarrays analysis carried out on brain RNA 
extracted from adult rats treated with the drugs. The selection of these miRNAs was 
done taking into account the following parameters:  
-High fold change of its expression levels following the antidepressant 
treatment; 
-Have a validated gene target for the evaluation of their activity. 
 
The selected miRNAs mir-136, mir-302b and mir-214 were further evaluated for 
their effects on neuronal morphology and survival as well as BDNF translation in vitro.  
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Evaluation of miRNAs effects was performed using rat hippocampal neuronal 
cultures, which were subject of transfection with miRNAs mimics and inhibitors. These 
are synthetic oligonucleotides which mimic endogenous mature miRNAs: the mimics 
produce a decrease of gene expression while the inhibitor lead to an inhibition of the 
endogenous miRNA, allowing us to achieve conditions similar to the endogenous up- or 
down-regulation of miRNAs to further gene expression and phenotypic analysis. In the 
absence of an established protocol to neuronal transfection with miRNAs, it was 
mandatorily to set-up the conditions to do these experiments.  
To the establishment of the protocol we have followed a specific line of reasoning to 
guarantee not only the neuronal transfection with the miRNAs but also their inhibitory 
activity into the cells. According to this, we started to identify the best concentration of 
miRNAs to transfect the largest number of neurons in culture. Since these 
oligonucleotides are not fluorescently labeled and therefore it is impossible to track 
them, it was necessary the use of the BLOCK-iT (Invitrogen), a red-labeled dsRNA 
oligomer with similar length, charge and configuration to the miRs, without a homology 
to any known gene avoiding the silencing of neuronal proteins. We experimentally 
verified that the correct concentration of miRNAs oligos to reach the highest neuronal 
transfection efficiency is either 50 or 100nM. Moreover, evaluation of the impact of the 
used concentrations of BLOCK-iT on neuronal survival did not show any significant 
effect on cell density. However, transfection with Lipofectamine2000 reagent showed a 
slight toxic effect on neurons, since cell density in these cases is decreased, but not 
significantly. These results show that such concentrations of synthetic oligonucleotides 
are not letal for neuronal cells.  
Since information provided by the supplier refers that concentration of miRNAs 
inhibitors should be higher than the concentration of miRNAs mimics to obtain the 
 
70 
inhibition of the endogenous miRNA, we had to choose the concentration of 100nM for 
miRNAs inhibitors and 50nM for mimics. 
As miRNAs are small RNA molecules with affinity to mRNAs promoting their 
degradation or translation inhibition (Lang et al., 2012) and consequent decrease on 
protein expression, we focused our attention in the quantification of the target proteins 
expression. With this purpose we searched for experimentally validated targets for the 
three miRNAs to be evaluated. Through bioinformatic analysis using miRWalk 
database we have chosen one target for each miRNA (see results, table 5) based on its 
neuronal expression and involvement in crucial pathways of neuronal development and 
connectivity. After neuronal transfection with both miRs mimics and inhibitors we have 
quantified the protein expression by densitometric analysis. This approach allowed us to 
quantify the expression levels of the protein target by miRNAs and correlate it with 
miRNAs activity. As we achieved a decrease of 17-36 % and an increase of about 14-26 
% upon miRs mimics or inhibitors transfection, respectively, we can assume that 
miRNAs have activity in neurons. These small changes are similar to those mediated by 
endogenous miRNAs and are in agreement with the characteristic of miRNAs to control 
biological processes through slight variations in the levels of target proteins. 
Furthermore, as miRNAs have many possible targets, miRs mimics/inhibitors may 
affect other mRNAs having a general action on the total endogenous mRNAs targets, 
explaining why we do not see strong changes in the selected protein target. In these 
experiments we have also evaluated the effect of miRNAs transfection on neuronal 
survival but we did not observe any significant change. This result is important to 
demonstrate that transfection with miRNAs does not have a cytotoxic effect and that 
protein decrease produced by miRNAs is not being prejudicial to neuronal survival. 
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The importance of miRNAs on the modulation of the neuronal morphology is 
generally accepted (Shratt et al., 2006; Magill et al., 2010; Agostini et al., 2011; Zhang 
et al., 2011; White et al., 2012). As antidepressant drugs altered the expression of some 
miRNAs it was hypothesized that their therapeutic effects are achieved, at least in part, 
by miRNAs-mediated gene regulation benefiting depression´s recovery. Morphological 
measurements of hippocampal neurons at 6 and 12 DIV have shown a modulation effect 
for the mimics-132 and -134. These miRNAs were previously described in literature as 
positive (mir-132) (Vo et al., 2005; Magill et al., 2010) and negative (mir-134) (Schratt 
et al., 2006) modulators of neuronal morphology, since they can increase or decrease, 
respectively the neuronal arborization outgrowth. Taking this into account, our results in 
which the mimic-132 and -134 produce an increase and decrease of the total dendritic 
length, respectively, is in agreement with previous studies. However, inhibitors did not 
show any impact on the neuronal morphology. Our data on miR-inhibitors can be 
compared only with a previous study in which mir-132 was genetically ablated by gene 
mutagenesis (Vo et al., 2005) showing significant impact on dendrites length. The 
divergent results may be explained by different technical bases of these studies and/or 
by a too low concentration of the miR-inhibitors used here. 
Previous studies had present evidences for the role of miRNAs on cellular 
viability either by enhancing cell proliferation (Zhong et al., 2012) or causing cell death 
(Fang et al., 2012) through gene expression regulation. The evaluation of viability of 
PC12 cells (pheochomocytoma cells) at 48 and 72h demonstrated the cytotoxic effect of 
the miRNAs transfection for this cell line. In fact, at 48h was observed the decrease of 
about half of the cell survival; nevertheless, there was a recovery of cell survival at 72h 
which in some cases was similar to the control. The rescue of cell viability at 72h can be 
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explained by the higher capacity of proliferation of these cells after a first cytotoxic 
effect occurring upon the initial transfection. 
Many miRNAs can target BDNF inducing its decrease, which may explain the 
neuronal plasticity impairment observed in depressed patients (Blugeot et al., 2011). 
Therefore, it is important to understand what impact the miRNAs modulated by 
antidepressant drugs may have on BDNF mRNA. The quantification of BDNF protein 
after incubation with miRs mimics/inhibitors demonstrate that, except for mir-132, for 
which is observed a tendency to modulate the BDNF expression (it is slightly increased 
with the mir-132 inhibitor and slightly decreased with the mir-132mimic), there are no 
changes in the BDNF expression for the others miRNAs. Results obtained with 
preliminary densitometric quantification on soma or full dendrites with miRNAs 
treatments did not show a strong variance in the BDNF expression. However, the miR-
132 and mir-134 were previously described as modulators of BDNF expression (Shratt 
et al., 2006; Kawashima et al., 2010) and since miRNAs inhibitory action may modulate 
protein translation in different ratios among the neuronal cells in culture, evaluation of 
this parameter with another kind of approach or statistical analysis would be of great 
importance.  For that reason, a new analysis of stained coltures is currently in progress 
and will give new insight at specific subcellular domains (Magill et al. 2010) involved 
in BDNF translation miRNA regulated.  
The modulation of the neuronal morphology by miRNAs raises the question of 
the involvement of BDNF on it, since it is recognized the implication of this 
neurotrophin in morphological features. Thus, it is important to know whether 
morphological alterations mediated by miRNAs are due to BDNF expression 
regulation. A significant number of miRNAs target BDNF gene and an even higher 
number of these molecules are predicted to target it. Through bioinformatics analysis it 
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was possible to get the miRNAs that are already validated or only predicted to target 
BDNF gene and regulate its expression. Generally, such regulation is mediated by the 
interaction miRNA-mRNA that is done mostly in the 3’UTR. In fact, among the 
miRNAs validated or merely predicted to target BDNF, 65 target the 3’UTR and the 
majority of them in the long portion of the 3’UTR region. This observation may imply a 
differential targeting and regulation of the two BDNF transcripts populations having 
either a short or a long 3’UTR. Therefore, translational inhibition of BDNF proteins 
originated by the two types of transcripts may have different implications in the 
development or homeostasis of neuronal cells. 
While initially, a previous studies have presented evidence for the differential 
target of the BDNF transcripts according to the 3’ UTR in resting neurons (An et al., 
2008), two recent study showed that both short and long 3’UTR BDNF transcripts can 
be targeted to dendrites (Baj et al., 2011; Yoneda et al., 2011). Dendritic targeting is 
apparently due to cytoplasmic polyadenilation element (CPE)-like sequences present in 
both the short and the long 3’ UTRs (Yoneda et al., 2011); however, it was observed 
that only transcripts with the long 3’UTR can reach the distal part of neuronal cells (Baj 
et al., 2011). 
Experiments were performed in hippocampal neurons from BDNF
lox
 mice 
(Gorski et al., 2003) in which the BDNF gene is truncated for the long 3’UTR and, thus, 
merely expresses the short 3´UTR BDNF transcripts, allowing us to evaluate the role of 
the BDNF proteins translated from the two populations of BDNF mRNA transcripts. 
Truncation of the long 3’UTR of BDNF resulted in a smaller dendritic length of 
neuronal cells in either young or already matured neurons, i.e. at 6 and 12 DIV. 
However, it is important to notice that there were no differences between WT, 
heterozygous and BDNF
lox
 mice at 9 DIV. Nevertheless, the number of primary and 
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secondary dendrites and branching points did not change in the absence of the long 3’ 
UTR at any time point. Taken together, these observations indicate that long 3’ UTR is 
necessary for the growth of the final regions of the dendrites and that such role is more 
important at dynamic stages of neuronal development.  
Another parameter analyzed in our study was the polarization of neuronal cells 
in culture. Pyramidal hippocampal neurons are characterized by their asymmetric 
dendritic arbor (Horton et al., 2006). The dendritic dynamic is represented by the 
extension and retraction of the dendrites and it is during this developmental stage that 
one dendrite becomes larger and bigger than the surrounding dendrites. The evaluation 
of this parameter demonstrat that truncation of long 3’UTR does not have implications 
on neuronal polarization since the percentage of polarized neurons as well as the 
dendrites rank, which evaluate the contribution of each dendrite to the final dendritic 
length, were similar among the three genotypes. Afterwards, spine morphology of WT, 
heterozygous and BDNF
lox
 mice was evaluated in order to see if the long 3’UTR has an 
important role in the structure and function of dendritic spines. The categorization of the 
spines present in the proximal and distal fields of the apical dendrite demonstrated that 
there is a switch of spine types during neuronal development. At earlier stages, stubby 
spines are present in a higher number and then they diminish with maturation giving 
rise to thin and mushroom spines, what is in agreement with the process of spine 
development (Papa et al. 1995). Although this development was observed in all 
genotypes, we found at late developmental stages (12 DIV) a lower number of 
mushroom spines in distal fields of BDNF
lox
 mice hippocampal neurons. Concerning 
the spine density at both proximal and distal dendritic fields, we did not observe any 
changes in the absence of the long 3´UTR. 
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Besides a qualitative and quantitative analysis of the spine types we also 
quantified the colocalization between PSD-95 and SynI, to evaluate the presence of 
synapses. This evaluation shows a decrease of about 25% and 35% in the colocalization 
in BDNF
lox
 mice at 6 and 12 DIV, respectively, which means that truncation of long 
3’UTR has severe consequences in the connectivity of hippocampal neurons. 
Taken together, these results suggest that not only the spine maturation in terms 
of the development of spines to mushroom spines, the most mature dendritic spines, but 
also the neuronal connectivity is dramatically impaired. However, it is important to 
notice that negative changes in spine function takes place only in distal fields, which 
goes in agreement with the target of the BDNF proteins translated from the long 3’UTR 
mRNA to the dendrites and its redundancy with the 3’UTR short in shaping the spine 
morphology at proximal fields. As the short 3’UTR BDNF cannot reach the most distal 
parts of the dendrites, it is in that area that the absence of the long 3’UTR is visible. 
A very recent study performed by Kaneko et al. (2012) has presented evidences 
in agreement with our results concerning the impairment of spine maturation. However, 
a divergent but interesting observation regarding dendritic spines morphology was in 
what concerns the impact of long 3’UTR in the spine density. In this study, cortical 
neurons only with short 3’UTR BDNF transcripts presented an increase in the spine 
density in the distal fields (Kaneko et al., 2012) which is explained by the authors as a 
result of the deficient spine pruning in this situation. Dendritic spines are overproduced 
at postnatal life especially in cortical neurons, but at a certain point there is an 
elimination of up to 40% of the spines while the remaining spines become mature and 
support the synaptic activity in the brain (Marin-Padilla, 1967; Huttenlocher, 1979). 
Thus, it is suggested that the lack of the long 3’ UTR may prevent the spine pruning 
(Kaneko et al., 2012). In this manner, comparing with neuronal cells with the two 
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populations of BDNF transcripts where there is a normal spine pruning, the spine 
density of BDNF
lox
 mice is higher since there is not an elimination of the spines. 
Although there is an established role for spine pruning in the cortex, there is a 
remarkable lack of information regarding spine pruning in hippocampus. In fact, 
although without significant variances, a slightly decrease in the BDNF
lox 
mice was 
observed in our study. This result can be due to a different spine development in the 
hippocampus. A previous study carried out in our lab in which we evaluated the spine 
development, showed a growing number of spines during 15 days in vitro, at any time 
point during development was observed spine pruning and consequent spine decrease 
(Baj, Patrizio, Montalbano, Sciancalepore and Tongiorgi, in preparation). So far, spine 
pruning in hippocampal neurons are only connected to synaptic plasticity after a 
procedure of extinction (Garin-Aguilar et al., 2012) but not in a normal spine 
development. 
As both populations of BDNF transcripts are transcribed in the same manner, 
only differing in the polyadenilation processing (Aid et al., 2007), truncation of the long 
3’UTR does not affect the transcription of the BDNF gene but rather the targeting of 
dendritic distal parts. However, it remains unclear how this long 3’UTR affect both 
translation and active mRNA transport in dendrites. 
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6. CONCLUSIONS 
 
 
The results obtained in this study have highlighted important aspects concerning 
the role of the 3’UTR long in the function and development of hippocampal neurons. 
BDNF
lox
 mice, truncated for the long 3’ UTR BDNF, showed deficiencies in total 
dendritic length of hippocampal neurons and even structural and functional synaptic-
modifications. These results are important to many fields of research, including the 
study of the depression´s mechanism. Since miRNAs are dysregulated in depressed 
patients, it was important to evaluate their effects on neuronal cells. Our results suggest 
that miRNAs modulated by antidepressant treatment during two weeks do not have any 
effects on neuronal morphology and survival. Their effects on BDNF expression levels 
are still unclear and new statistical analysis should be performed, however, it cannot be 
discarded the possibility of a BDNF expression modulation, which could impact mostly 
at synapses. Since many miRNAs are putative or validated targets of BDNF gene, 
mainly in the 3´UTR, it can be possible that miRNAs upregulated in depression could 
target the long 3’UTR of BDNF explaining, together with the dysregulation of other 
proteins, the diminished synaptic plasticity observed in depressed patients. 
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7. FUTURE PERSPECTIVES 
 
 
As evaluation of the miRNAs effects on the modulation of the BDNF translation 
in hippocampal neurons through densitometric analysis did not present conclusive 
results, it is already ongoing another type of analysis based on a different statistical 
approach. Moreover, the quantification of BDNF levels will be furthermore explored 
through Western Blot or ELISA techniques in order to confirm the results from 
densitometric analysis. Likewise, the number of hippocampal neurons for the 
assessment of the proteins expression levels will be increased to achieve a more 
representative ratio for the protein level after up- or down- regulation of miRNAs.  
Finally, a new set of experiments using a multiple miRNAs modulation 
approach to study in vitro a condition of RNA regulation will be done to achieve a more 
representative depression status. 
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